<?xml version="1.0" encoding="iso-8859-1"?>
		<rss version="2.0" >
        <channel>
        <title>rellease ID</title>
        <link>https://relleaseid.com/</link>
        <description>situs relleaseID</description>
        <language>en-us</language>
        <pubDate>Wed, 21 Oct 2026 12:35:14 +0700</pubDate>
        <lastBuildDate>Wed, 21 Oct 2026 12:35:14 +0700</lastBuildDate>
        <generator>rellease ID RSS Generator</generator>
        <managingEditor>relleaseid@gmail.com</managingEditor>
        <webMaster>arie.vcr@gmail.com</webMaster>
		<image>
		<url>https://relleaseid.com/icon.gif</url>
		<title>rellease ID</title>
		<link>https://relleaseid.com/</link>
		<description>Fasilitas RSS dari relleaseID</description>
		</image>
<item>
<title>UEG Week: Teva and Sanofi&#039;s Duvakitug Maintained Long-Term Positive Outcomes in New Phase 2b Data for Ulcerative Colitis and Crohn&#039;s Disease</title>
<link>https://relleaseid.com/berita-bisnis/UEG-Week--Teva-and-Sanofi--039-s-Duvakitug-Maintained-Long-Term-Positive-Outcomes-in-New-Phase-2b-Data-for-Ulcerative-Colitis-and-Crohn--039-s-Disease</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/6156_UEG-Week--Teva-and-Sanofi--039-s-Duvakitug-Maintained-Long-Term-Positive-Outcomes-in-New-Phase-2b-Data-for-Ulcerative-Colitis-and-Crohn--039-s-Disease.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>*In UC, duvakitug maintained high rates of clinical remission, clinical response, and endoscopic improvement at Week 44</div><div>*In CD, duvakitug maintained high rates of endoscopic response, clinical response, and clinical remission at Week 44</div><div>*Duvakitug was well tolerated and safety was consistent with the induction study</div><div><br></div><div>PARSIPPANY, N.J. and PARIS, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Sanofi announced new positive data from the RELIEVE UCCD phase 2b long-term extension (LTE) study (clinical trial identifier: NCT05668013) in patients with moderately-to-severely active ulcerative colitis (UC) or Crohn&#039;s disease (CD), which demonstrated that duvakitug maintained clinically meaningful efficacy improvements across multiple endpoints over 44 weeks. </div><div><br></div><div>Duvakitug is an investigational human monoclonal antibody that targets TL1A, a protein that amplifies inflammation and potentially drives fibrosis in UC and CD.</div><div><br></div><div>In addition, biomarker findings that advance the understanding of how duvakitug may impact inflammation and tissue remodeling in inflammatory bowel disease (IBD) were shared. These data were presented today at United European Gastroenterology (UEG) Week 2026 in Barcelona.</div><div><br></div><div>The RELIEVE UCCD LTE study evaluated the efficacy, safety, and tolerability of duvakitug through 44 weeks of maintenance treatment after induction in patients with UC and CD, the two most common forms of IBD. Patients (n=130, 72 with UC and 58 with CD) who responded to duvakitug treatment in the 14-week induction study were randomized to receive either duvakitug 450 mg or 900 mg subcutaneously every four weeks (Q4W) for up to 58 weeks of total exposure.</div><div><br></div><div>UC Results</div><div>At Week 44, maintenance treatment with duvakitug demonstrated high rates of clinical remission and clinical response, as measured by the modified Mayo Score (mMS), meaning active UC symptoms such as rectal bleeding, increased stool frequency, and pain have stopped (remission) or improved (response). Duvakitug treatment also achieved high rates of endoscopic improvement, defined by a Mayo Endoscopic Score of 0 (inactive disease in the colon) or 1 (mild disease activity), which measures the presence and degree of intestinal inflammation. Efficacy outcomes were numerically higher at 900 mg compared to 450 mg, consistent with a dose response.&nbsp;</div><div><br></div><div><table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0">
 <tbody><tr>
  <td colspan="3" valign="top" style="border:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span style="font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"">Efficacy in UC at Week 44
  Maintenance Phase Endpoint<o:p></o:p></span></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span style="font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"">&nbsp;<o:p></o:p></span></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal"><span style="font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"">Duvakitug
  450 mg Q4W<br>
  [n=34]<o:p></o:p></span></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal"><span style="font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"">Duvakitug
  900 mg Q4W<br>
  [n=38]<o:p></o:p></span></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span style="font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"">Clinical remission (mMS)<o:p></o:p></span></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal"><span style="font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"">47%<br>
  [95% CI: 30, 65]<o:p></o:p></span></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal"><span style="font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"">58%<br>
  [95% CI: 42, 73]<o:p></o:p></span></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span style="font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"">Clinical response (mMS)<o:p></o:p></span></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal"><span style="font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"">82%<br>
  [95% CI: 61, 91]&nbsp;<o:p></o:p></span></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal"><span style="font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"">87%<br>
  [95% CI: 71, 94]<o:p></o:p></span></p>
  </td>
 </tr>
 <tr>
  <td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span style="font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"">Endoscopic improvement<o:p></o:p></span></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal"><span style="font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"">59%<br>
  [95% CI: 42, 76]<o:p></o:p></span></p>
  </td>
  <td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal"><span style="font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"">63%<br>
  [95% CI: 47, 78]&nbsp;<o:p></o:p></span></p>
  </td>
 </tr>
 <tr>
  <td colspan="3" valign="top" style="border:solid black 1.0pt;border-top:none;
  padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal"><span style="font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"">Data
  are descriptive. Confidence intervals (CIs) are based on logistic regression.<o:p></o:p></span></p>
  </td>
 </tr>
 <tr>
  <td colspan="3" style="padding:.75pt .75pt .75pt .75pt">
  <p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span style="font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"">&nbsp;<o:p></o:p></span></p>
  </td>
 </tr>
</tbody></table></div><div>"Ulcerative colitis can have a significant impact on patients that disrupts even the most basic daily activities. Despite available therapies, some patients continue to experience flares that impact their lives in various ways and may contribute to disease progression," said Walter Reinisch, MD, PhD, Director of the Inflammatory Bowel Disease Study Group at the Medical University of Vienna and a co-lead investigator of the RELIEVE UCCD LTE study. "These results underscore the potential of duvakitug to deliver effective and durable relief from persistent inflammation and symptoms, supporting better long-term disease management in patients with ulcerative colitis."</div><div><br></div><div>CD Results</div><div>Duvakitug maintenance treatment demonstrated high rates of endoscopic response, defined as a 50% or more decrease from baseline in Simple Endoscopic Score for Crohn&#039;s Disease (SES-CD) at Week 44. SES-CD assesses mucosal ulcers, the ulcerated surface, the endoscopic extension, and the presence of stenosis in the colon as a gauge of disease severity. Additionally, duvakitug maintained high rates of clinical response and clinical remission as measured by the Crohn&#039;s Disease Activity Index (CDAI), meaning symptoms such as abdominal pain, diarrhea, and fatigue have stopped (remission) or improved (response). Duvakitug appeared to demonstrate a dose response, with numerically higher efficacy results achieved at the higher dose.&nbsp;</div><div><br></div><div><table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" style="background-color: rgb(255, 255, 255);"><tbody><tr><td colspan="3" valign="top" style="border:solid black 1.0pt;padding:.75pt .75pt .75pt 7.5pt"><p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span style="font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"">Efficacy in CD at Week 44
  Maintenance Phase Endpoint<o:p></o:p></span></p></td></tr><tr><td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt"><p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span style="font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"">&nbsp;<o:p></o:p></span></p></td><td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt"><p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal"><span style="font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"">Duvakitug
  450 mg Q4W<br>
  [n=27]<o:p></o:p></span></p></td><td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt"><p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal"><span style="font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"">Duvakitug
  900 mg Q4W<br>
  [n=31]<o:p></o:p></span></p></td></tr><tr><td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt"><p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span style="font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"">Endoscopic response<o:p></o:p></span></p></td><td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt"><p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal"><span style="font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"">41%<br>
  [95% CI: 25, 62]<o:p></o:p></span></p></td><td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt"><p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal"><span style="font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"">55%<br>
  [95% CI: 39, 75]<o:p></o:p></span></p></td></tr><tr><td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt"><p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span style="font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"">Clinical response (CDAI)<o:p></o:p></span></p></td><td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt"><p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal"><span style="font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"">81%<br>
  [95% CI: 63, 94]<o:p></o:p></span></p></td><td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt"><p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal"><span style="font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"">87%<br>
  [95% CI: 70, 96]<o:p></o:p></span></p></td></tr><tr><td valign="top" style="border:solid black 1.0pt;border-top:none;padding:.75pt .75pt .75pt 7.5pt"><p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span style="font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"">Clinical remission (CDAI)<o:p></o:p></span></p></td><td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt"><p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal"><span style="font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"">81%<br>
  [95% CI: 65, 95]<o:p></o:p></span></p></td><td valign="top" style="border-top:none;border-left:none;border-bottom:solid black 1.0pt;
  border-right:solid black 1.0pt;padding:.75pt .75pt .75pt .75pt"><p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal"><span style="font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"">84%<br>
  [95% CI: 68, 96]<o:p></o:p></span></p></td></tr><tr><td colspan="3" valign="top" style="border:solid black 1.0pt;border-top:none;
  padding:.75pt .75pt .75pt .75pt"><p class="MsoNormal" align="center" style="margin-bottom:0in;margin-bottom:.0001pt;
  text-align:center;line-height:normal"><span style="font-size:12.0pt;
  font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman"">Data
  are descriptive. Confidence intervals (CIs) are based on logistic regression.<o:p></o:p></span></p></td></tr><tr><td colspan="3" style="padding:.75pt .75pt .75pt .75pt"><p class="MsoNormal" style="margin-bottom:0in;margin-bottom:.0001pt;line-height:
  normal"><span style="font-size:12.0pt;font-family:"Times New Roman","serif";
  mso-fareast-font-family:"Times New Roman"">&nbsp;<o:p></o:p></span></p></td></tr></tbody></table></div><div>"Due to the heterogeneous nature of Crohn&#039;s disease, many patients either stop responding or never respond to available therapies, leaving them with uncontrolled symptoms that cause physical distress," said Vipul Jairath, MBChB, DPhil, FRCP, FRCPC, Professor of Medicine in the Departments of Medicine, Epidemiology and Biostatistics at Western University and a co-lead investigator of the RELIEVE UCCD LTE study. "The efficacy rates seen with duvakitug in the maintenance period highlight its potential as a new treatment option that could help more patients achieve sustained remission."</div><div><br></div><div>Across both UC and CD, duvakitug was generally well tolerated throughout the maintenance period, with a safety profile consistent with the induction phase and no new safety concerns identified. The most frequently reported adverse events (AEs) occurring in &#8805;5% of patients across pooled duvakitug dose groups in UC were upper respiratory tract infection and nasopharyngitis, and in CD were upper respiratory tract infection, CD, hypertension, nasopharyngitis, anemia, and influenza. The majority of AEs were mild or moderate in severity. Discontinuation rates due to AEs were low (UC, 4% and 2% in the 450 mg and 900 mg arms, respectively, and in CD were 6% in each arm).</div><div><br></div><div>Biomarker Results</div><div>Biomarker analyses from the RELIEVE UCCD induction study (clinical trial identifier: NCT05499130) were presented at UEG Week 2026. Duvakitug reduced blood levels of markers connected to multiple inflammatory pathways in UC and to the Th17 and Th1 immune pathways in CD, as well as markers of neutrophilic inflammation in both blood and tissue in CD and UC. In patients with CD, duvakitug also reduced markers of tissue remodeling. These findings provide additional mechanistic evidence that TL1A inhibition may address both inflammation and, potentially, fibrosis.</div><div><br></div><div>Additionally, clinical results from the RELIEVE UCCD induction study were recently published in The Lancet Gastroenterology and Hepatology for UC and CD.</div><div><br></div><div>Duvakitug Clinical Development Program</div><div>Duvakitug is being investigated in the phase 3 SUNSCAPE-1 (clinical trial identifier: NCT07184996) and SUNSCAPE-2 (clinical trial identifier: NCT07185009) studies in moderately-to-severely active UC, and the phase 3 STARSCAPE-1 (clinical trial identifier: NCT07184931) and STARSCAPE-2 (clinical trial identifier: NCT07184944) studies in moderately-to-severely active CD. Sanofi and Teva have initiated the phase 2 AURALIGHT study (clinical trial identifier: NCT07812116) of duvakitug in moderate-to-severe hidradenitis suppurativa and are planning a phase 2 study of duvakitug in fibrostenotic Crohn&#039;s disease.</div><div><br></div><div>Duvakitug is currently under clinical investigation, and its efficacy and safety have not been evaluated by any regulatory authority.</div><div><br></div><div>About IBD</div><div>Inflammatory bowel disease (IBD) is an autoimmune disorder characterized by chronic inflammation of the gastrointestinal (GI) tract. Globally, approximately 4.9 million cases of IBD have been identified, with incidence rising in several regions. The two main types of IBD are ulcerative colitis (UC) and Crohn&#039;s disease (CD), which are characterized by repetitive cycles of relapses and remission. Common symptoms of both conditions include persistent diarrhea, rectal bleeding, abdominal pain, loss of appetite, and weight loss.</div><div><br></div><div>Prolonged inflammation can lead to damage within the GI tract, including fibrosis, a common complication of IBD characterized by an excessive accumulation of scar tissue in the intestinal wall, which may cause narrowing and obstruction.</div><div><br></div><div>Currently, there is no cure for IBD. The goal of current treatment is to induce and maintain remission and prevent flares.</div><div><br></div><div>About the RELIEVE UCCD phase 2b program</div><div>The RELIEVE UCCD program is comprised of an induction study and a long-term extension (LTE).</div><div><br></div><div>RELIEVE UCCD: A 14-week phase 2b, randomized, double-blinded, dose-ranging induction study to evaluate the efficacy, safety, pharmacokinetics, and tolerability of duvakitug in adults with moderate-to-severe ulcerative colitis (UC) or Crohn&#039;s disease (CD). The study was an innovative and efficient basket study design allowing the inclusion of patients with either UC or CD. It is the first and only randomized, blinded and placebo-controlled phase 2 study to investigate the impact of TL1A inhibition in CD.</div><div><br></div><div>RELIEVE UCCD LTE: An ongoing phase 2b study to evaluate the long-term efficacy and safety of duvakitug. Patients who received duvakitug, completed the 14-week induction study, and were responders, entered a 44-week double-blind maintenance period and were re-randomized to receive either 450 mg or 900 mg of subcutaneous duvakitug every four weeks. Patients who completed the 44-week maintenance period may continue to receive duvakitug in an open-label extension.</div><div><br></div><div>Primary efficacy endpoints for both the 14-week induction study and the 44-week maintenance period are clinical remission (as defined by mMS) in the UC cohort or endoscopic response (as defined by SES-CD) in the CD cohort. The study includes sites in the US, Europe, Israel, and Asia.</div><div><br></div><div>About duvakitug&nbsp;</div><div>Duvakitug is a human monoclonal antibody targeting tumor necrosis factor-like ligand 1A (TL1A) being developed to reduce inflammation and potentially fibrosis. Duvakitug is currently in phase 3 clinical studies for the treatment of ulcerative colitis and Crohn&#039;s disease and is also being investigated in hidradenitis suppurativa and fibrostenotic Crohn&#039;s disease. The safety and efficacy of duvakitug have not been reviewed by any regulatory authority.</div><div><br></div><div>About the Sanofi and Teva collaboration</div><div>Sanofi and Teva are collaborating to co-develop and co-commercialize duvakitug for the treatment of ulcerative colitis and Crohn&#039;s disease, as well as fibrostenotic Crohn&#039;s disease and hidradenitis suppurativa. Each company will equally share the development costs globally, and the net profits and losses in major markets, with other markets subject to a royalty arrangement. Teva will lead commercialization of the product in Europe, Israel, and specified other countries, and Sanofi will lead commercialization in North America, Japan, other parts of Asia, and the rest of the world.</div><div><br></div><div>About Teva</div><div>Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is transforming into a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva&#039;s commitment to bettering health has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients&#039; needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how, visit www.tevapharm.com.</div><div><br></div><div>Cautionary Note Regarding Forward-Looking Statements</div><div>This Press Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management&#039;s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. You can identify these forward-looking statements by the use of words such as "should," "expect," "anticipate," "estimate," "target," "may," "project," "intend," "plan," "believe" and other words and terms of similar meaning and expression in connection with any discussion of future operating or financial performance. Important factors that could cause or contribute to such differences include risks relating to: our ability to successfully develop duvakitug for the treatment of ulcerative colitis (UC) and Crohn&#039;s disease (CD) as well as fibrostenotic Crohn&#039;s disease and hidradenitis suppurativa; our ability to successfully compete in the marketplace, including our ability to develop and commercialize additional pharmaceutical products; our ability to successfully execute on our Pivot to Growth strategy, including to expand our innovative and biosimilar medicines pipeline and to profitably commercialize our innovative medicines and biosimilar portfolio, whether organically or through business development; our significant indebtedness; our business and operations in general; compliance, regulatory and litigation matters; financial, economic and other risks; and other factors discussed in our Quarterly Report on Form 10-Q for the second quarter of 2026 and in our Annual Report on Form 10-K for the year ended December 31, 2025, including in the sections captioned "Risk Factors" and "Forward-Looking Statements." Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.</div><div><br></div><div>About Sanofi</div><div>Sanofi is an R&D driven, AI-powered biopharma company committed to improving people&#039;s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more.&#8239;Our team is guided by one purpose: we chase the miracles of science to improve people&#039;s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time.&nbsp;</div><div><br></div><div>Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY</div><div><br></div><div>Sanofi forward-looking statements</div><div>This press release contains forward-looking statements within the meaning of applicable securities laws, including the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions, and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future events and economic performance. Words such as "expect," "anticipate," "believe," "intend," "estimate," "plan," "can," "contemplate," "could," "is designed to," "may," "might," "potential," "objective," "attempt," "target," "project," "strategy," "strive," "desire," "predict," "forecast," "ambition," "guideline," "seek," "should," "will," "goal,"&nbsp; or the negative of these, and similar expressions are intended to identify forward-looking statements. Although Sanofi&#039;s management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the U.S. Food and Drug Administration or the European Medicines Agency, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labelling and other matters that could affect the availability or commercial potential of such product candidates; the fact that product candidates if approved may not be commercially successful; unexpected regulatory actions or delays, or government regulation generally; authorities&#039; decisions regarding whether and when to approve a product candidate; political pressure in the United States to mandate lower drug prices including "most favored nation" pricing for State Medicaid programs; the future approval and commercial success of therapeutic alternatives; Sanofi&#039;s ability to benefit from external growth opportunities, to complete related transactions and/or obtain regulatory clearances, including future clinical data and analysis of existing clinical data relating to the product, including post marketing, unexpected safety, quality or manufacturing issues, competition in general; risks associated with intellectual property and any related pending or future litigation and the ultimate outcome of such litigation;&#8239; trends in exchange rates and prevailing interest rates, volatile economic and market conditions, cost containment initiatives and subsequent changes thereto, and the impact that global crises may have on us, our customers, suppliers, vendors, and other business partners, and the financial condition of any one of them, as well as on our employees and on the global economy as a whole.&nbsp; The risks and uncertainties also include the uncertainties discussed or identified in the public filings with the SEC and the French Markets Authority (AMF) made by Sanofi, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in Sanofi&#039;s annual report on Form 20-F for the year ended December 31, 2025 or contained in our periodic reports on Form 6-K. Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements. Considering these risks, uncertainties, and assumptions, you should not place undue reliance on any forward-looking statements contained herein.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Wed, 21 Oct 2026 08:56:00 +0700</pubDate>
</item>
<item>
<title>LEPAS Launches Inaugural Global Elegant Lifestyle Week, Welcoming Users Worldwide to Wuhu</title>
<link>https://relleaseid.com/berita-bisnis/LEPAS-Launches-Inaugural-Global-Elegant-Lifestyle-Week--Welcoming-Users-Worldwide-to-Wuhu</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/3015_LEPAS-Launches-Inaugural-Global-Elegant-Lifestyle-Week--Welcoming-Users-Worldwide-to-Wuhu.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>WUHU, China, Oct. 20, 2026 (GLOBE NEWSWIRE) -- From October 19 to 23, the 2026 Chery International User Summit is bringing together users, media representatives and ecosystem partners from around the world in Wuhu. Under the theme "HIGH TECH FOR OUR FUTURE LIFE", the summit will explore the future of intelligent, low-carbon and sustainable mobility and lifestyles.</div><div><br></div><div>This is the first image.</div><div><br></div><div>During the summit, Chery Auto will showcase advances in green energy manufacturing, intelligent charging and Robotaxi technology, while AiMOGA Robotics will demonstrate intelligent services through live interactions. From charging and autonomous driving to robotics, technology is making everyday life more convenient.</div><div><br></div><div> As mobility expectations evolve beyond reaching a destination, comfort and quality of life are gaining importance. Through interactive experiences and global user exchanges, the summit will explore how technology can enrich daily life and connect brands with users.</div><div><br></div><div>As Chery Auto&#039;s Premium NEV brand, LEPAS responds to users&#039; expectations for distinctive design, intelligent convenience and comfort through its three core pillars: Leopard Aesthetics, Elegant Technology and Exquisite Space. As LEPAS launches and delivers its NEV lineup worldwide, users are experiencing these pillars firsthand. From first impressions of a vehicle&#039;s exterior and cabin in the showroom to daily commutes and longer journeys, users are discovering what "Drive Your Elegance" means through everyday driving experiences.</div><div><br></div><div>As these experiences reach different markets, local tastes, road conditions and ways of life shape different perspectives on elegance. The summit brings these experiences and personal stories together in Wuhu, giving LEPAS and its global users an opportunity to exchange ideas and collaborate in person.</div><div><br></div><div>On October 18, LEPAS launched its inaugural Global Elegant Lifestyle Week. The first LEPAS owners, partners, industry media and Global Elegant Lifestyle Partners from different regions began arriving in Wuhu for the event, held under the theme "TOGETHER IN ELEGANCE."</div><div><br></div><div>This is the second image.</div><div><br></div><div>During the week, participants will explore elegance through four dimensions: design, technology, driving and lifestyle. They will share driving experiences, exchange cultural perspectives on aesthetics and explore elegant living across cultures with LEPAS. Their feedback will inform LEPAS&#039;s product, service and brand development.</div><div><br></div><div>Throughout the week, LEPAS will bring elegance to life through shared experiences. The LEPAS Global Journey of Elegant Driving and practical demonstrations will showcase composed driving on real roads and the convenience of intelligent technology in everyday situations. The LEPAS All-New Concept Car will offer a vision of future mobility design, while Global Elegance Night will bring together different cultures and personal stories.</div><div><br></div><div>Beyond driving experiences, LEPAS seeks to build deeper connections with users and partners worldwide through shared ideas and collaboration. The relationships formed in Wuhu will extend beyond the event, bringing LEPAS&#039;s vision of elegance into everyday life.</div><div><br></div><div>About LEPAS</div><div><br></div><div>LEPAS is Chery Auto&#039;s Premium NEV brand, dedicated to creating elegant mobility experiences for users worldwide. Committed to becoming the Preferred Brand for Elegant Mobility Life, LEPAS brings together Leopard Aesthetics, Elegant Technology, and Exquisite Space - transforming elegance into a driving experience you can see, feel, and trust. </div><div><br></div><div>Supported by a growing global dealer network of more than 500 sales and service outlets, LEPAS is expanding its international footprint through localized operations, delivering products and experiences tailored to users across global markets.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Wed, 21 Oct 2026 08:50:00 +0700</pubDate>
</item>
<item>
<title>Wuzhen Summit Puts Spotlight on Tongxiang&#039;s Expanding AI Industry</title>
<link>https://relleaseid.com/berita-bisnis/Wuzhen-Summit-Puts-Spotlight-on-Tongxiang--039-s-Expanding-AI-Industry-2</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/9719_Wuzhen-Summit-Puts-Spotlight-on-Tongxiang--039-s-Expanding-AI-Industry.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div><div>The CenoBot S5 autonomous cleaning robot undergoes real-world testing at a demonstration site in Tongxiang.<span style="white-space: pre;">	</span>&nbsp;</div><div><br></div></div><div>TONGXIANG, CHINA - Media OutReach Newswire - 20 October 2026 - The 2026 World Internet Conference Wuzhen Summit will open on Nov. 2, bringing technology leaders, researchers and companies to the historic water town as Tongxiang firms expand AI applications from commercial cleaning and autonomous delivery to industrial control and data-center cooling.</div><div><br></div><div>For Tongxiang, long associated with the annual internet conference, the summit is also a chance to demonstrate how local companies are commercializing AI technologies for customers at home and abroad.</div><div><br></div><div>Ahead of the event, reporters visited seven Tongxiang-based companies working in robotics, intelligent vehicles, synthetic data, industrial automation, logistics and computing infrastructure.</div><div><br></div><div>Singapore Changi Airport earlier this year placed a fourth order for commercial cleaning robots from CenoBots, a Tongxiang-based company whose machines are used in airports, supermarkets, hospitals, factories and warehouses.</div><div><br></div><div>CenoBots has sold products in more than 40 countries and regions. Its customers include Changi Airport, British retailer Tesco, the University of Minnesota and pharmaceutical company Novo Nordisk. This year, the company supplied about 600 autonomous cleaning robots for Tesco Express stores across the United Kingdom.</div><div><br></div><div>"Cleaning robots are appearing in more and more settings," said Shen Jizhong, CenoBots&#039; co-founder and vice president. "It is much like electric vehicles becoming a familiar sight on the roads - a trend that is gathering pace."</div><div><br></div><div>The company&#039;s machines are adapted to different settings. Hospital robots must move through busy corridors without disrupting patient care, while those used in supermarkets navigate around shoppers and carts. Factory robots operate near forklifts, and airport models must handle both fine debris in carpeted areas and small obstacles on smooth floors.</div><div><br></div><div>CenoBots continues to refine its robots through real-world testing, focusing on reliable operation and consistent cleaning performance across diverse environments. The company has expanded its research, development and production facilities in Tongxiang from approximately 3,000 square meters in its early years to more than 20,000 square meters. Local malls, hospitals and sports venues have also served as long-term testing sites.</div><div><br></div><div>While CenoBots focuses on service robots, TEEMO is developing the vehicle platforms that support autonomous mobility. The company makes drive-by-wire skateboard chassis and core components for autonomous vehicles used in last-mile delivery, patrols and logistics.</div><div><br></div><div>Its standardized chassis can be equipped with different vehicle bodies and hardware for specific uses. One of TEEMO&#039;s strategic customers, autonomous delivery-vehicle maker Zelos, was selected for all lots in China Post&#039;s centralized procurement program for 7,000 autonomous delivery vehicles.</div><div><br></div><div>TEEMO&#039;s customers already span the United States, the Middle East, India and Russia, said Zhang Yongjian, the company&#039;s director of operations.</div><div><br></div><div>"In some overseas markets, distances are long, populations are dispersed and last-mile delivery is difficult to staff," Zhang said. "Autonomous delivery vehicles have strong potential there, and overseas business will become an important growth driver for us."</div><div><br></div><div>Other Tongxiang companies are concentrating on the data and perception systems that allow machines to function in physical environments.</div><div><br></div><div>Dayan Technology, founded in Tongxiang in May 2025, provides synthetic-data and toolchain services for autonomous-driving and humanoid-robotics companies. It combines real-world data collection, digital twins and simulated training environments to help developers train robots before they are deployed.</div><div><br></div><div>Its wearable devices record human movement and interactions with objects. A haptic glove uses liquid-metal and pressure sensors to capture hand gestures, finger movements and contact force. A multi-camera headset records a user&#039;s visual field, body posture, hand movements and the position of nearby objects.</div><div><br></div><div>Dayan said its tactile-perception model can process touch signals in milliseconds. The technology is intended to help robots do more than identify objects visually: They can learn how firmly to grip an item, recognize when it is slipping and apply force without causing damage.</div><div><br></div><div>Freetech is applying related sensing and decision-making capabilities to intelligent driving. The company develops intelligent-driving systems and 4D imaging radar for passenger and commercial vehicles, and said its technology has been selected for hundreds of vehicle programs.</div><div><br></div><div>Its ODIN AI platform supports products at different levels of driving automation. The radar is designed to complement cameras in heavy rain, fog, darkness and abrupt changes in light, including when vehicles enter or leave tunnels.</div><div><br></div><div>At its intelligent-manufacturing base in Wuzhen, Freetech is also using AI in production. An in-house system reads customer orders and calculates the components and materials needed for each production line before manufacturing begins. The company said the system has increased overall efficiency by more than 20%.</div><div><br></div><div>"Transportation combined with a specialized function will be an important direction for the future," said Dr. Zhang Lin, Freetech&#039;s founder and CEO.</div><div><br></div><div>Freetech sees potential applications beyond passenger vehicles, including robots, elder-care vehicles, mining equipment and agricultural machinery.</div><div><br></div><div>Beyond mobility, Tongxiang firms are using AI to address the complexity of industrial operations. Founded in 2019, Shuhan Technologies provides on-premises industrial AI for chemical plants, energy facilities and wastewater-treatment systems. Its AI-driven control layer continuously ingests data from central control systems and field sensors, identifies dynamic conditions and autonomously adjusts operating parameters in real time.</div><div><br></div><div>"Fundamentally, all industrial process challenges can be framed as control and optimization problems," said Zhai Zhengjun, Shuhan&#039;s Chief Technology Officer.</div><div><br></div><div>At a coal chemical plant with annual capacity of 1.2 million metric tons, Shuhan said its system reduced raw-material consumption by 6%. The company estimated that the deployment generated more than 176 million yuan, or about $26 million, in annualized economic benefits and reduced carbon emissions by more than 500,000 metric tons.</div><div><br></div><div>SENAD is targeting bottlenecks in logistics operations, including loading, unloading, sorting and pallet handling. It develops autonomous loading and unloading robots, as well as a multimodal logistics model called Robot Insight, for sectors including beverages, tobacco, consumer goods, pharmaceuticals and logistics.</div><div><br></div><div>Tongxiang&#039;s AI sector also includes companies addressing the infrastructure needed to run increasingly powerful computing systems. SynthCool is tackling a basic constraint of the AI boom: heat.</div><div><br></div><div>SynthCool develops two-phase liquid-cooling systems to address the heat generated by increasingly powerful processors. Inadequate cooling can trigger thermal throttling, reducing performance and energy efficiency.</div><div><br></div><div>"Heat dissipation is infrastructure," said Zhu Zhijiang, SynthCool&#039;s general manager.</div><div><br></div><div>SynthCool&#039;s two-phase cooling technology uses the latent heat of vaporization to remove heat from processors. The cooling fluid absorbs heat and boils into vapor, which is then condensed back into liquid and recirculated.</div><div><br></div><div>Depending on ambient conditions and system design, two-phase cooling can also support free cooling and reduce reliance on compressor-based refrigeration. Waste heat may be recovered where temperatures and local demand make reuse practical.</div><div><br></div><div>According to SynthCool, its technology supports heat dissipation of more than 3,000 watts per chip and heat flux above 250 watts per square centimeter. Under comparable cooling requirements, the system requires approximately one-third of the flow needed by conventional single-phase water-cooled cold plates, helping reduce piping requirements and pumping demand.</div><div><br></div><div>SynthCool&#039;s portfolio includes two-phase direct-to-chip and immersion cooling solutions, along with distribution units and control systems for AI data centers.</div><div><br></div><div>The issuer is solely responsible for the content of this announcement.</div><div><br></div><div>Hashtags: #Tongxiang</div><div><br></div>   ]]></description>
<pubDate>Wed, 21 Oct 2026 08:43:00 +0700</pubDate>
</item>
<item>
<title>Wuzhen Summit Puts Spotlight on Tongxiang&#039;s Expanding AI Industry</title>
<link>https://relleaseid.com/berita-bisnis/Wuzhen-Summit-Puts-Spotlight-on-Tongxiang--039-s-Expanding-AI-Industry</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/4124_Wuzhen-Summit-Puts-Spotlight-on-Tongxiang--039-s-Expanding-AI-Industry.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div><div>The CenoBot S5 autonomous cleaning robot undergoes real-world testing at a demonstration site in Tongxiang.<span style="white-space: pre;">	</span>&nbsp;</div><div><br></div></div><div>TONGXIANG, CHINA - Media OutReach Newswire - 20 October 2026 - The 2026 World Internet Conference Wuzhen Summit will open on Nov. 2, bringing technology leaders, researchers and companies to the historic water town as Tongxiang firms expand AI applications from commercial cleaning and autonomous delivery to industrial control and data-center cooling.</div><div><br></div><div>For Tongxiang, long associated with the annual internet conference, the summit is also a chance to demonstrate how local companies are commercializing AI technologies for customers at home and abroad.</div><div><br></div><div>Ahead of the event, reporters visited seven Tongxiang-based companies working in robotics, intelligent vehicles, synthetic data, industrial automation, logistics and computing infrastructure.</div><div><br></div><div>Singapore Changi Airport earlier this year placed a fourth order for commercial cleaning robots from CenoBots, a Tongxiang-based company whose machines are used in airports, supermarkets, hospitals, factories and warehouses.</div><div><br></div><div>CenoBots has sold products in more than 40 countries and regions. Its customers include Changi Airport, British retailer Tesco, the University of Minnesota and pharmaceutical company Novo Nordisk. This year, the company supplied about 600 autonomous cleaning robots for Tesco Express stores across the United Kingdom.</div><div><br></div><div>"Cleaning robots are appearing in more and more settings," said Shen Jizhong, CenoBots&#039; co-founder and vice president. "It is much like electric vehicles becoming a familiar sight on the roads - a trend that is gathering pace."</div><div><br></div><div>The company&#039;s machines are adapted to different settings. Hospital robots must move through busy corridors without disrupting patient care, while those used in supermarkets navigate around shoppers and carts. Factory robots operate near forklifts, and airport models must handle both fine debris in carpeted areas and small obstacles on smooth floors.</div><div><br></div><div>CenoBots continues to refine its robots through real-world testing, focusing on reliable operation and consistent cleaning performance across diverse environments. The company has expanded its research, development and production facilities in Tongxiang from approximately 3,000 square meters in its early years to more than 20,000 square meters. Local malls, hospitals and sports venues have also served as long-term testing sites.</div><div><br></div><div>While CenoBots focuses on service robots, TEEMO is developing the vehicle platforms that support autonomous mobility. The company makes drive-by-wire skateboard chassis and core components for autonomous vehicles used in last-mile delivery, patrols and logistics.</div><div><br></div><div>Its standardized chassis can be equipped with different vehicle bodies and hardware for specific uses. One of TEEMO&#039;s strategic customers, autonomous delivery-vehicle maker Zelos, was selected for all lots in China Post&#039;s centralized procurement program for 7,000 autonomous delivery vehicles.</div><div><br></div><div>TEEMO&#039;s customers already span the United States, the Middle East, India and Russia, said Zhang Yongjian, the company&#039;s director of operations.</div><div><br></div><div>"In some overseas markets, distances are long, populations are dispersed and last-mile delivery is difficult to staff," Zhang said. "Autonomous delivery vehicles have strong potential there, and overseas business will become an important growth driver for us."</div><div><br></div><div>Other Tongxiang companies are concentrating on the data and perception systems that allow machines to function in physical environments.</div><div><br></div><div>Dayan Technology, founded in Tongxiang in May 2025, provides synthetic-data and toolchain services for autonomous-driving and humanoid-robotics companies. It combines real-world data collection, digital twins and simulated training environments to help developers train robots before they are deployed.</div><div><br></div><div>Its wearable devices record human movement and interactions with objects. A haptic glove uses liquid-metal and pressure sensors to capture hand gestures, finger movements and contact force. A multi-camera headset records a user&#039;s visual field, body posture, hand movements and the position of nearby objects.</div><div><br></div><div>Dayan said its tactile-perception model can process touch signals in milliseconds. The technology is intended to help robots do more than identify objects visually: They can learn how firmly to grip an item, recognize when it is slipping and apply force without causing damage.</div><div><br></div><div>Freetech is applying related sensing and decision-making capabilities to intelligent driving. The company develops intelligent-driving systems and 4D imaging radar for passenger and commercial vehicles, and said its technology has been selected for hundreds of vehicle programs.</div><div><br></div><div>Its ODIN AI platform supports products at different levels of driving automation. The radar is designed to complement cameras in heavy rain, fog, darkness and abrupt changes in light, including when vehicles enter or leave tunnels.</div><div><br></div><div>At its intelligent-manufacturing base in Wuzhen, Freetech is also using AI in production. An in-house system reads customer orders and calculates the components and materials needed for each production line before manufacturing begins. The company said the system has increased overall efficiency by more than 20%.</div><div><br></div><div>"Transportation combined with a specialized function will be an important direction for the future," said Dr. Zhang Lin, Freetech&#039;s founder and CEO.</div><div><br></div><div>Freetech sees potential applications beyond passenger vehicles, including robots, elder-care vehicles, mining equipment and agricultural machinery.</div><div><br></div><div>Beyond mobility, Tongxiang firms are using AI to address the complexity of industrial operations. Founded in 2019, Shuhan Technologies provides on-premises industrial AI for chemical plants, energy facilities and wastewater-treatment systems. Its AI-driven control layer continuously ingests data from central control systems and field sensors, identifies dynamic conditions and autonomously adjusts operating parameters in real time.</div><div><br></div><div>"Fundamentally, all industrial process challenges can be framed as control and optimization problems," said Zhai Zhengjun, Shuhan&#039;s Chief Technology Officer.</div><div><br></div><div>At a coal chemical plant with annual capacity of 1.2 million metric tons, Shuhan said its system reduced raw-material consumption by 6%. The company estimated that the deployment generated more than 176 million yuan, or about $26 million, in annualized economic benefits and reduced carbon emissions by more than 500,000 metric tons.</div><div><br></div><div>SENAD is targeting bottlenecks in logistics operations, including loading, unloading, sorting and pallet handling. It develops autonomous loading and unloading robots, as well as a multimodal logistics model called Robot Insight, for sectors including beverages, tobacco, consumer goods, pharmaceuticals and logistics.</div><div><br></div><div>Tongxiang&#039;s AI sector also includes companies addressing the infrastructure needed to run increasingly powerful computing systems. SynthCool is tackling a basic constraint of the AI boom: heat.</div><div><br></div><div>SynthCool develops two-phase liquid-cooling systems to address the heat generated by increasingly powerful processors. Inadequate cooling can trigger thermal throttling, reducing performance and energy efficiency.</div><div><br></div><div>"Heat dissipation is infrastructure," said Zhu Zhijiang, SynthCool&#039;s general manager.</div><div><br></div><div>SynthCool&#039;s two-phase cooling technology uses the latent heat of vaporization to remove heat from processors. The cooling fluid absorbs heat and boils into vapor, which is then condensed back into liquid and recirculated.</div><div><br></div><div>Depending on ambient conditions and system design, two-phase cooling can also support free cooling and reduce reliance on compressor-based refrigeration. Waste heat may be recovered where temperatures and local demand make reuse practical.</div><div><br></div><div>According to SynthCool, its technology supports heat dissipation of more than 3,000 watts per chip and heat flux above 250 watts per square centimeter. Under comparable cooling requirements, the system requires approximately one-third of the flow needed by conventional single-phase water-cooled cold plates, helping reduce piping requirements and pumping demand.</div><div><br></div><div>SynthCool&#039;s portfolio includes two-phase direct-to-chip and immersion cooling solutions, along with distribution units and control systems for AI data centers.</div><div><br></div><div>The issuer is solely responsible for the content of this announcement.</div><div><br></div><div>Hashtags: #Tongxiang</div><div><br></div>   ]]></description>
<pubDate>Wed, 21 Oct 2026 08:43:00 +0700</pubDate>
</item>
<item>
<title>YYForce AI Humanoid Housekeepers to be trained in Novotel Hotel</title>
<link>https://relleaseid.com/berita-bisnis/YYForce-AI-Humanoid-Housekeepers-to-be-trained-in-Novotel-Hotel</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/4827_YYForce-AI-Humanoid-Housekeepers-to-be-trained-in-Novotel-Hotel.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>Acquires 20 wearable data collection systems to capture real-world housekeeping tasks to support robot learning and development</div><div><br></div><div>SINGAPORE, Oct. 20, 2026 (GLOBE NEWSWIRE) -- YYForce Inc. (NASDAQ: YFOR) ("YYForce" or the "Company"), a technology-enabled provider of workforce solutions, integrated facility management and commercial robotics services, today announced the acquisition of 20 wearable data collection systems to support its humanoid robotics development program.</div><div><br></div><div>The systems, comprising head-mounted egocentric cameras and synchronized wrist-mounted cameras, are intended to capture first-person views and close-up recordings of human task execution. YYForce plans to deploy the equipment through an initiative with the housekeeping team at Novotel Singapore on Stevens, focusing initially on selected hospitality workflows.</div><div><br></div><div>The initiative is designed to build a task-specific dataset documenting how experienced housekeeping personnel perform routine service activities. Following review, annotation and technical processing, the demonstrations are intended to support robot learning research, task development and evaluation, including work involving vision-language-action (VLA) models.</div><div><br></div><div>Initial Focus: Housekeeping Demonstrations</div><div><br></div><div>Planned data collection will focus on selected tasks, including:</div><div><br></div><div>Bed and linen preparation: Bed-making sequences, linen handling and pillow arrangement.</div><div>Towel and amenity organization: Towel folding, placement and replenishment of guest-room supplies.</div><div>Selected cleaning activities: Surface wiping and handling of cleaning tools and materials.</div><div>These demonstrations are intended to capture task sequences, hand-object interactions and variations in real operating environments. Translating human demonstrations into robot capabilities will require additional processing, adaptation to the selected robotic hardware, and controlled testing.</div><div><br></div><div>"Access to real operating environments and experienced service teams is an important part of our robotics development strategy," said Mike Fu, Chief Executive Officer of YYForce. "This initiative will help us document how housekeeping tasks are performed in practice and assess how those demonstrations can support humanoid robot learning. Our focus is on building useful datasets, validating individual tasks and progressing toward practical applications in hospitality and facility services."</div><div><br></div><div>Supporting YYForce&#039;s Workforce and Robotics Strategy</div><div><br></div><div>The initiative supports YYForce&#039;s broader strategy of combining workforce expertise, facility management operations and robotics to develop technology-enabled service delivery.</div><div><br></div><div>The planned development process includes reviewing recordings for quality, annotating selected tasks, preparing suitable training datasets and evaluating whether the demonstrations improve performance on defined robotic tasks. Initial evaluation will focus on task completion, repeatability and safe execution under controlled conditions.</div><div><br></div><div>Data collection is planned to follow agreed hotel operating procedures and applicable data protection requirements. The Company expects that collection arrangements will address participant notification and consent where required, guest privacy, access controls and permitted uses of recorded material before recording begins.</div><div><br></div><div>The initiative is a development-stage program. The acquisition of the systems and collection of demonstrations do not, by themselves, establish autonomous humanoid capabilities or readiness for commercial deployment.</div><div><br></div><div>About YYForce Inc.</div><div><br></div><div>YYForce Inc. (NASDAQ: YFOR) is a technology-enabled provider of workforce solutions and integrated facility management and commercial robotics services. The Company is developing AI-enabled workforce platforms and expanding its commercial robotics capabilities to support customers across hospitality, facilities management and other service industries.</div><div><br></div><div>For more information, please visit www.yyforce.ai.</div><div><br></div><div>Forward-Looking Statements</div><div>This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company bases these forward-looking statements on its expectations and projections about future events derived from information currently available to it. </div><div><br></div><div>You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. </div><div><br></div><div>Forward-looking statements include statements regarding planned equipment deployment, data collection, robotics training, technical development and potential commercial applications. These statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially.</div><div><br></div><div>Such risks include equipment performance, data quality and usability, data rights and privacy requirements, collaboration arrangements, technical challenges in transferring human demonstrations to robotic systems, development costs, safety validation and commercial adoption, together with other risks described in the Company&#039;s filings with the U.S. Securities and Exchange Commission, including under "Risk Factors" in its most recent annual report. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. YYForce undertakes no obligation to update these statements except as required by law.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Wed, 21 Oct 2026 08:38:00 +0700</pubDate>
</item>
<item>
<title>Heinekenteams up with Amazon to launch &quot;Pubscription&quot; ... The world&#039;s first streaming service for nights out</title>
<link>https://relleaseid.com/berita-bisnis/Heinekenteams-up-with-Amazon-to-launch--quot-Pubscription-quot------The-world--039-s-first-streaming-service-for-nights-out</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/4203_Heinekenteams-up-with-Amazon-to-launch--quot-Pubscription-quot------The-world--039-s-first-streaming-service-for-nights-out.jpg border=0 hspace=5 align=left width=350 /><div><div><br></div><div>*New Fire TV experience uses the familiar mechanics of streaming discovery to help people find their next night out</div><div>*Users can browse participating pubs and bars by "genre", invite friends and receive a weekly credit for a Heineken or Heineken 0.0</div><div>*The launch comes as over half of adults worldwide say they would go out more often if discovering where to go was as easy as discovering something to watch</div><div><br></div><div>AMSTERDAM, Oct. 20, 2026 (GLOBE NEWSWIRE) -- We&#039;re all familiar with the new era of TV viewing: abundant choice, personalised recommendations and effortless discovery. Streaming has transformed how we discover entertainment, with something to watch just seconds away. Now, that same approach can help people discover where to go out, too.</div><div><br></div><div>As much as people love the ease of streaming, they still crave time together IRL. The challenge is that organising a night out can often feel like too much hassle compared to how effortless entertainment discovery has become. In a poll of 15,000 adults worldwide, over half (55%) say they would go out more often if discovering where to go was as easy as discovering something to watch, while almost two-thirds (59%) say they would be more likely to try somewhere new if they had recommendations tailored to their interests and mood.</div><div><br></div><div>To make getting together as simple as saying yes to another episode, Heineken, the champion of IRL socialising, has collaborated with Amazon to launch &#039Pubscription&#039;, the first streaming service for nights out.</div><div><br></div><div>Currently being piloted in the UK, the new Fire TV experience takes inspiration from the simplicity and personalisation of streaming, applying the same approach of deciding what to watch to where to go out. The app helps you find a pub or bar that matches your mood, invite friends and enjoy a free weekly Heineken or Heineken 0.0 together.</div><div><br></div><div>Nabil Nasser, Global Head of Heineken, said: "At Heineken, we believe life is better when it&#039;s shared. But as our lives become increasingly digital, creating those moments of real-world connection has never felt more important.</div><div><br></div><div>Pubscription uses the simplicity we&#039;ve come to expect from streaming to do something very human: help friends get together, discover a great pub and spend time with each other.</div><div><br></div><div>Technology can give us endless ways to be entertained, but nothing replaces the simple pleasure of getting together over a Heineken."</div><div><br></div><div>Developed in collaboration with Brand Innovation Lab, the creative arm of Amazon Ads, Pubscription allows users aged 18+ to browse participating pubs and bars by "genre", depending on the kind of night they&#039;re after, from lively sports pubs to relaxed local hangouts with friends. Users can subscribe for free via the age-gated Pubscription app on Fire TV and redeem their weekly voucher on their smartphone. They can then invite friends to join them and discover new places together. Each month, Subscribers will receive four vouchers, which can be redeemed for a Heineken or Heineken 0.0 at any participating Star Pub, with a limit of one redemption per week.</div><div><br></div><div>Notes to editors</div><div>Media contact:</div><div>heinekenpubscription@wearetheromans.com</div><div><br></div><div>Research Credits:</div><div>*Heineken commissioned a survey of 15,000 respondents across the United States, United Kingdom, Spain, Brazil, France, Romania, United Arab Emirates, South Africa, India, South Korea.</div><div><br></div><div>The global poll of 15,000 adults found:</div><div><br></div><div>Out of those that stream, over half (55%) do so after 6pm on weekends, rising to almost two thirds (63%) on weekday evenings.</div><div>Almost a third (30%) say they make spontaneous plans to meet friends less often than they did five years ago.</div><div>One in three (31%) say they value memories with friends and family most when going out and socialising.</div><div>Over two in five (41%) say having IRL conversations is one of the main reasons they value going out.</div><div><br></div><div>*Separately, Heineken commissioned Statista to supply global data on streaming and socialising between 2022 and 2025, which shows the rise in streaming:</div><div><br></div><div>Globally, people spent more than two and a half hours a day streaming in 2025, compared with just half an hour socialising, showing how central digital entertainment has become to daily life. Pubscription aims to channel that same enthusiasm into discovering great nights out.</div><div>Annual content viewing hours reached 748 billion in 2025, up 33 billion year-on-year.</div><div><br></div><div>About Heineken</div><div>HEINEKENis the world&#039;s most international brewer. It is the leading developer and marketer of premium beer and cider brands. Led by the Heinekenbrand, the Group has a portfolio of more than 300 international, regional, local and specialty beers and ciders. We are committed to innovation, long-term brand investment, disciplined sales execution and focused cost management. Through "Brewing a Better World", sustainability is embedded in the business. HEINEKENhas a well-balanced geographic footprint with leadership positions in both developed and developing markets.</div><div><br></div><div> We employ over 85,000 employees and operate breweries, malteries, cider plants and other production facilities in more than 70 countries. HeinekenN.V. and HeinekenHolding N.V. shares trade on the Euronext in Amsterdam. Prices for the ordinary shares may be accessed on Bloomberg under the symbols HEIA NA and HEIO NA and on Reuters under HEIN.AS and HEIO.AS. HEINEKENhas two sponsored level 1 American Depositary Receipt (ADR) programmes: HeinekenN.V. (OTCQX: HEINY) and HeinekenHolding N.V. (OTCQX: HKHHY)</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div></div><div><br></div>   ]]></description>
<pubDate>Wed, 21 Oct 2026 08:32:00 +0700</pubDate>
</item>
<item>
<title>Chow Tai Fook Jewellery Group Welcomes President of Botswana to Its Newly Opened Signature Boutique in Beijing</title>
<link>https://relleaseid.com/berita-bisnis/Chow-Tai-Fook-Jewellery-Group-Welcomes-President-of-Botswana-to-Its-Newly-Opened-Signature-Boutique-in-Beijing</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/4863_Chow-Tai-Fook-Jewellery-Group-Welcomes-President-of-Botswana-to-Its-Newly-Opened-Signature-Boutique-in-Beijing.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>Mr Kent Wong, Managing Director of Chow Tai Fook Jewellery Group (left) welcomes President of Botswana Duma Gideon Boko (right) to the newly opened signature boutique at Beijing SKP, during his State Visit to China, and the President presents a heartfelt message to the Group</div><div><br></div><div>President of Botswana Duma Gideon Boko&#039;s visit underscores Botswana&#039;s longstanding ties with Chow Tai Fook across the natural diamond value chain</div><div><br></div><div>BEIJING, CHINA - Media OutReach Newswire - 20 October 2026 - During his State Visit to China, President of the Republic of Botswana Duma Gideon Boko led a delegation to visit the newly opened signature boutique of Chow Tai Fook Jewellery Group Limited ("Chow Tai Fook Jewellery", the "Group" or the "Company"; SEHK stock code: 1929) at Beijing SKP on 14 October, for an exchange on China-Botswana cooperation across the natural diamond value chain.</div><div><br></div><div> Mr Kent Wong, Managing Director of Chow Tai Fook Jewellery Group, welcomed President Boko and the delegation, highlighting the Group&#039;s longstanding ties with Botswana&#039;s diamond industry and sharing how Chow Tai Fook creates new value to natural diamonds through cultural heritage reinterpretation and contemporary design.</div><div><br></div><div>President Boko&#039;s visit took place as China and Botswana elevated bilateral relations to a comprehensive strategic cooperative partnership. The two countries also agreed to deepen cooperation in the diamond sector and enhance access for Botswana&#039;s diamond products to the Chinese market.</div><div><br></div><div>Mr Kent Wong, Managing Director of Chow Tai Fook Jewellery Group, said, " We are deeply honoured to welcome President Boko to Chow Tai Fook in Beijing. Botswana holds an important place in the global natural diamond value chain and in Chow Tai Fook&#039;s own journey with natural diamonds. </div><div><br></div><div>Our longstanding partnerships with Botswana&#039;s diamond industry and De Beers Group reflect a shared commitment to the enduring value of natural diamonds. We look forward to continuing to contribute our expertise in craftsmanship, design and retail to enhance consumer confidence in natural diamonds and support the industry&#039;s sustainable development."</div><div><br></div><div>Deepening ties across the natural diamond value chain</div><div><br></div><div>Botswana is one of the world&#039;s leading diamond-producing countries, and diamonds are an important pillar of China-Botswana economic cooperation. The latest China-Botswana Joint Statement identifies the diamond sector as an area for further cooperation, including improved access for Botswana&#039;s diamond products to the Chinese market.</div><div><br></div><div>Chow Tai Fook has deep roots in the natural diamond industry, underpinned by established global sourcing capabilities. The Group&#039;s relationship with De Beers Group dates back to 1973, when Chow Tai Fook became a De Beers Group Sightholder. Since 2011, Chow Tai Fook has operated its own diamond cutting and polishing facility in Botswana, extending the Group&#039;s involvement across the value chain from sourcing and craftsmanship to jewellery design and retail.</div><div><br></div><div>Chow Tai Fook has also been an early advocate of diamond traceability. Launched in 2016, T?MARK enables customers to trace the journey of selected diamonds from sourcing, cutting and polishing to certification and setting. In FY2026, all newly procured T?MARK diamonds were traceable to their country of origin.</div><div><br></div><div>Reimagining natural diamonds through Chinese creativity</div><div><br></div><div>Natural diamonds embody both the extraordinary beauty of nature and the emotions and memories that jewellery carries across generations. Through design and craftsmanship, Chow Tai Fook brings Chinese cultural heritage into a contemporary context, creating natural diamond jewellery that resonates with evolving lifestyles and expressions of individuality.</div><div><br></div><div>In September 2026, Chow Tai Fook participated in the signing of the Beijing Declaration on Natural Diamonds and Sustainable Development. Convened by The Shanghai Diamond Exchange, the initiative brought together government representatives from Botswana, Namibia and South Africa, as well as members of the Chinese and international diamond industry. It supports closer engagement between diamond-producing countries and the Chinese market, while advancing consumer understanding of the enduring value of natural diamonds.</div><div><br></div><div>Chow Tai Fook and De Beers Group also recently launched the Desert Rose Collection, inspired by desert rose stone formations and the resilience of plants thriving in arid landscapes. The collaboration builds on the two companies&#039; longstanding relationship and their shared focus on strengthening consumer appreciation and confidence in natural diamonds.</div><div><br></div><div>Looking ahead, Chow Tai Fook will continue to invest in design, craftsmanship and consumer engagement, while working with partners across the natural diamond value chain to support the industry&#039;s sustainable development and contribute to deeper ties between China and Botswana.</div><div><br></div><div>About De&#8239;Beers Group</div><div>Established in 1888, De Beers Group is the world&#039;s leading diamond company with expertise in the exploration, mining, marketing and retailing of diamonds. Together with its joint venture partners, De Beers Group employs more than 20,000 people across the diamond pipeline and is the world&#039;s largest diamond producer by value, with diamond mining operations in Botswana, Canada, Namibia and South Africa. </div><div><br></div><div>Innovation sits at the heart of De Beers Group&#039;s strategy as it develops a portfolio of offers that span the diamond value chain, including its jewellery houses, De Beers London and Forevermark, and other pioneering solutions such as diamond sourcing and traceability initiatives Tracr and GemFair. </div><div><br></div><div>De Beers Group also provides leading services and technology to the diamond industry in the form of education and laboratory services and a wide range of diamond sorting, detection and classification technology services. De Beers Group is committed to &#039;Building Forever,&#039; a holistic and integrated approach to sustainability that underpins our efforts to create meaningful impact for the people and places where our diamonds are discovered. </div><div><br></div><div>Building Forever focuses on three key areas where, through collaborations and partnerships around the globe, we have an enhanced ability to drive positive impact; Livelihoods, Climate and Nature. De Beers Group is a member of the Anglo American plc group. For further information, visit www.debeersgroup.com.</div><div><br></div><div>About Chow Tai Fook Jewellery Group Limited</div><div>Since its founding in 1929, CHOW TAI FOOK, the flagship brand of Chow Tai Fook Jewellery Group, has been celebrated for its bold designs and meticulous attention to detail. Our commitment to innovation and craftsmanship has made us synonymous with excellence, value, and authenticity.</div><div><br></div><div>As a global Chinese luxury group, we blend contemporary designs with traditional techniques to create timeless pieces. Each collection reflects our customers&#039; stories and lives, celebrating their special moments. We aspire to inspire and captivate generations to come, weaving the story of CHOW TAI FOOK into their own.</div><div><br></div><div>Our brand portfolio includes the iconic CHOW TAI FOOK flagship brand, HEARTS ON FIRE, ENZO, and MONOLOGUE, offering a wide variety of products, including an expanding range of cuttingedge IP collaborations. With over 5,000 stores worldwide, we offer a seamless client journey across all touchpoints through a network spanning China and a growing number of global locations.</div><div><br></div><div>Chow Tai Fook Jewellery Group Limited (SEHK: 1929) has been listed on the Main Board of the Hong Kong Stock Exchange since December 2011. We are committed to delivering sustainable long-term value for our stakeholders by continually enhancing earnings quality and driving higher value growth.</div><div><br></div><div>The issuer is solely responsible for the content of this announcement.</div><div><br></div><div>Hashtags: #NaturalDiamonds #Diamonds #DeBeersGroup #BuildingForever</div><div><br></div>   ]]></description>
<pubDate>Wed, 21 Oct 2026 08:27:00 +0700</pubDate>
</item>
<item>
<title>Sovico and Hamburg Forge Partnership to Expand Vietnam-Germany Economic Ties</title>
<link>https://relleaseid.com/berita-bisnis/Sovico-and-Hamburg-Forge-Partnership-to-Expand-Vietnam-Germany-Economic-Ties</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/2712_Sovico-and-Hamburg-Forge-Partnership-to-Expand-Vietnam-Germany-Economic-Ties.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div><div>Sovico Group and the Free and Hanseatic City of Hamburg, sign a Partnership Agreement on October 13 to expand cooperation in aviation, railways, finance, logistics, technology and education.</div><div><br></div></div><div>HO CHI MINH CITY, VIETNAM - Media OutReach Newswire - 20 October 2026 - Sovico Group, one of Vietnam&#039;s leading private conglomerates, and the Free and Hanseatic City of Hamburg signed a Partnership Agreement at Saigon Marina IFC to expand cooperation in aviation, railways, finance, logistics, technology and education. </div><div><br></div><div>The agreement aims to connect Vietnamese businesses with Hamburg&#039;s industrial and commercial ecosystem and its role as a gateway to European markets.</div><div><br></div><div>Earlier that day, Hamburg First Mayor and President of the Senate Peter Tschentscher met Sovico Chairwoman Nguyen Thi Phuong Thao at HDBank&#039;s headquarters to discuss cooperation opportunities between businesses in the Sovico ecosystem and German partners.</div><div><br></div><div>At the Hamburg?Sovico Strategic Business & Partnership Forum 2026 on October 13, Thao proposed exploring direct air links between Vietnam and Germany and advancing discussions on airport infrastructure, logistics, urban rail, maritime transport and supporting industries. Hamburg highlighted its strengths in aviation, maritime transport, railways, technology research, public transport and sustainable urban development.</div><div><br></div><div>Potential areas for further discussion include the Long Thanh and Gia Binh airport projects, high-speed rail, urban rail development in Ho Chi Minh City, Dong Nai and Hanoi, smart cities, green industries and technology. The agreement provides a framework for exploring opportunities; participation in individual projects will require further study and subsequent agreements.</div><div><br></div><div>Sovico and its partners have maintained ties with Germany for more than three decades, particularly in aviation and finance. Hamburg has hosted the handover of more than 100 Airbus aircraft to Vietjet, alongside aircraft-financing services. In finance, DEG, a member of Germany&#039;s KfW Group, has invested in HDBank over the past five years. HDBank&#039;s German Desk also helps connect Vietnamese and German businesses and support bilateral trade and investment.</div><div><br></div><div>Thao said Sovico was entering a new investment phase, emphasizing the need for long-term vision, practical investment plans and effective coordination. "I hope the ideas exchanged here today will be translated into cooperation programmes, feasible projects and measurable outcomes," she said.</div><div><br></div><div>Hamburg State Secretary Liv Assmann said the visit aimed to deepen existing ties and explore new areas of cooperation. Agreements between universities in Hamburg and Vietnam are also expected to create opportunities for training, professional exchange and workforce development.</div><div><br></div><div>The issuer is solely responsible for the content of this announcement.</div><div><br></div><div>Hashtags: #HDBank</div>   ]]></description>
<pubDate>Wed, 21 Oct 2026 08:23:00 +0700</pubDate>
</item>
<item>
<title>Water shortages will threaten growth within five years, say over half of European industrial leaders</title>
<link>https://relleaseid.com/berita-bisnis/Water-shortages-will-threaten-growth-within-five-years--say-over-half-of-European-industrial-leaders</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/5805_Water-shortages-will-threaten-growth-within-five-years--say-over-half-of-European-industrial-leaders.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>*Water stress is already hitting operating costs, supply chains and infrastructure across European industry</div><div>*Water shortages now rank as high as cyber-attacks and supply chain disruption for industrial business continuity</div><div>*Nearly 60% of leaders admit to not installing the technology they know could cut water risk</div><div><br></div><div>PARIS, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Schneider Electric, a global energy technology leader, today released The Water Crunch Report, new research revealing that water is now one of the biggest risks to industrial business continuity across the UK and Europe, ranking as highly as cyber-attacks and supply chain disruption. </div><div><br></div><div>This echoes last year&#039;s US-focused research from Schneider Electric, where over half (56%) of business leaders said water-related risks will grow faster than other infrastructure risks in the coming years.</div><div><br></div><div>The Water Crunch Report surveyed senior leaders at industrial companies and decision-makers at water utilities and municipalities across Europe. In the past two years, industrial leaders say water stress has already pushed up their operating costs (44%), strained infrastructure and maintenance budgets (38%), and disrupted supply chains (30%). </div><div><br></div><div>If a serious water supply disruption hits tomorrow, 44% of businesses believe their operations would start to suffer within 24 hours. On average, over half (52%) of industrial leaders expect water quality or availability to become a serious barrier to their organization&#039;s growth within the next five years, by 2031, and 1 in 7 (14%) say it already is a barrier to their operations or growth today.</div><div><br></div><div>The findings land against the backdrop of Europe&#039;s most severe drought conditions in decades, with the knock-on effects on the freight, energy and agriculture sectors providing a stark reminder that these pressures are no longer hypothetical.</div><div><br></div><div>"Europe cannot afford to treat water as an environmental issue alone. It is now a competitiveness issue," said Gwenaelle Huet, Executive Vice President, Industrial Automation, Schneider Electric. "Just as the energy transition reshaped industrial strategy over the past decade, water efficiency will shape the next one. AI-powered industrial intelligence gives companies unprecedented visibility into how water is used, wasted and recycled. The challenge is no longer understanding the problem, but acting at the pace required to secure Europe&#039;s industrial future."</div><div><br></div><div>"It&#039;s easy to write off this summer&#039;s droughts and impact on industry as a one-off, but this is now a structural feature of operating in Europe," said Sophie Borgne, Water & Environment Segment President of Schneider Electric. "Right now, around half of the EU and UK are under some level of drought, according to the EU&#039;s European Drought Observatory. Reusing water can reduce our dependence on rivers and reservoirs already under strain, yet only 2.4% of treated urban wastewater is reused across the EU today. The organizations investing in smart water technology are turning water efficiency into a competitive advantage."</div><div><br></div><div>Awareness vs. adoption</div><div><br></div><div>Smart water technology is widely recognized as a solution to water management, but implementation is not keeping up with awareness. The gap isn&#039;t down to skepticism. Belief in these tools is close to universal: 86% of industrial leaders and 98% of water utilities say smart water technology can cut operating costs, and over 80% say it protects business continuity and strengthens sustainability performance.</div><div><br></div><div>Despite this, industrial leaders show particularly high awareness of technologies they haven&#039;t yet deployed: 58% are aware of digital twins or network modelling tools but have not installed them, while 57% of water utilities say the same of predictive analytics or AI-enabled water management.</div><div><br></div><div>The encouraging news is that industry isn&#039;t waiting for the problem to worsen. Nearly all organizations surveyed (100% of water utilities and 98% of industrial leaders) say water availability or quality has already shaped major decisions, from increased investment in water efficiency (47%) to formal board-level reviews of water risk (43%). More than half of industrial leaders surveyed have installed automated controls (56%) and smart meters (55%); smart meter adoption climbs even higher among water utilities, to 76%.</div><div><br></div><div>Cybersecurity is climbing up the agenda too, with over half of both industrial leaders and water utilities naming it among the top risks to manage as water systems become more connected and digital.</div><div><br></div><div>But there is clear headroom for growth: many leaders are aware of technologies designed to optimize operations but haven&#039;t yet installed them, meaning the biggest gains may still be ahead. For European business leaders, the takeaway is straightforward: water risk now needs the same active management as energy or cybersecurity. Closing this gap is likely to matter most for the industries already feeling the cost of water stress.</div><div><br></div><div>"For nearly two decades, water has been overlooked in the climate conversation, attracting a fraction of the investment given to energy or carbon. With Europe warming more than twice as fast as the rest of the world, pressure on water supply is intensifying, and The Water Crunch report confirms the mindset is shifting: 47% of industry leaders have already increased investment in water efficiency, and 43% have taken water risk to board level. Water security is finally being treated as a business priority, not an afterthought," said Tom Freyberg, independent water and environment expert.</div><div><br></div><div>Forward-thinking utilities are leveraging existing technologies to minimize impact on their customers. To ensure the supply security of its water network, the Danish utility, Aarhus Vand, relies on the forecasting capabilities of a digital twin. Schneider Electric&#039;s EcoStruxure Water Advisor - Water Simulation was deployed to help the utility remotely monitor its water supply network to easily and precisely identify potential leaks and supply fluctuations. </div><div><br></div><div>Using data from points on the network, Water Simulation anticipates the impact of planned and unplanned events so Aarhus Vand can take the best actions to address them quickly, minimizing waste and providing a reliable supply of high-quality water for its customers. The provider also benefits from lower energy use and costs thanks to improved efficiency.</div><div><br></div><div>Notes to Editors:</div><div>Schneider Electric is helping cities and businesses digitalize water infrastructure, transforming it from a hidden risk into a strategic advantage. From real-time leak detection to digital twins that simulate and optimize water flow, Schneider&#039;s smart water solutions reduce losses, improve reliability, and strengthen operational performance. More information on Schneider Electric&#039;s Water and Wastewater solutions can be found here.</div><div><br></div><div>Survey Methodology</div><div>The research was commissioned by Schneider Electric and conducted by Censuswide, with the survey questions designed in collaboration with independent water industry journalist and analyst Tom Freyberg, Founder of Atlantean Media. It explores how industrial leaders and water system decision-makers across the UK and Europe are experiencing water stress today, the strategic priorities related to water management and infrastructure, and the gap between recognizing water risk and acting on it.</div><div><br></div><div>The research was conducted in the UK, Ireland, Italy, France, Spain, Germany and the Nordics (Sweden and Denmark) in June 2026 and surveyed a total of 340 leaders comprised of two key groups:</div><div><br></div><div>210 industrial business leaders (Director-level and above) from large enterprises (1,000+ employees) across key industries including Energy & Chemicals, Manufacturing, Life Sciences & Pharmaceuticals, Industrial Machinery & Equipment, Semiconductors & Electronics, Construction and Food & Beverage.</div><div>130 water system decision-makers from utilities, municipalities/local government and public water infrastructure providers.</div><div><br></div><div>Additional sources:</div><div><br></div><div>Closed-loop industrial water recycling systems can recover up to 90% of process water: Envisioning/Stratum research on closed-loop water systems.</div><div>Only 2.4% of treated wastewater is currently reused across the EU: Interreg Europe/Europe&#039;s Freshwater portal.</div><div>Since the 1980s, Europe has warmed at more than twice the global rate, and European land temperatures are now roughly 2.3?2.5?C above pre-industrial levels, versus about 1.3-1.4C (celcius) globally: Copernicus Climate Change Service</div><div><br></div><div>Press contact: mediarelations@se.com</div><div><br></div><div>About Schneider Electric</div><div><br></div><div>Schneider Electric is a global energy technology leader, driving efficiency and sustainability by electrifying, automating, and digitalizing industries, businesses, and homes. Its technologies enable buildings, data centers, factories, infrastructure, and grids to&#8239;operate&#8239;as open, interconnected ecosystems, enhancing performance, resilience, and sustainability. </div><div><br></div><div>The portfolio includes intelligent devices, software-defined architectures, AI-powered systems, digital services, and expert advisory. With 160,000 employees and 1 million partners in over 100 countries, Schneider Electric is consistently ranked among the world&#039;s most sustainable companies.&nbsp;</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Wed, 21 Oct 2026 08:17:00 +0700</pubDate>
</item>
<item>
<title>Singapore Media Festival Returns for its 13th Edition with Refreshed Industry Focus and New Creator Summit</title>
<link>https://relleaseid.com/berita-bisnis/Singapore-Media-Festival-Returns-for-its-13th-Edition-with-Refreshed-Industry-Focus-and-New-Creator-Summit</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/3617_Singapore-Media-Festival-Returns-for-its-13th-Edition-with-Refreshed-Industry-Focus-and-New-Creator-Summit.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div><br></div><div>*Singapore Media Festival 2026 introduces Asia Creator Summit, a new event that brings together Asia&#039;s creator ecosystem to explore commercial opportunities in the creator economy</div><div>*Asia TV Forum & Market, a leading co-production and entertainment content market and conference in Asia, returns with over 5,000 content industry players from 60 countries and regions</div><div><br></div><div>SINGAPORE - Media OutReach Newswire - 20 October 2026 - The Singapore Media Festival (SMF) will return from 1 to 5 December 2026 for its 13th edition, reaffirming its commitment to connecting Singapore&#039;s media industry with opportunities across Asia and the world. </div><div><br></div><div>Hosted by the Infocomm Media Development Authority (IMDA), SMF 2026 will introduce the Asia Creator Summit (ACS), a new flagship event for Asia&#039;s creator ecosystem to discover how they can build sustainable businesses, develop intellectual property, and scale effectively across markets.</div><div><br></div><div>Alongside the new ACS, Asia TV Forum & Market (ATF) returns as a longstanding highlight of SMF and a leading co-production and entertainment content market and conference in Asia. The dual pillars of ACS and ATF demonstrate SMF&#039;s focus on supporting Singapore&#039;s media industry by creating new jobs through commercial opportunities, building industry skills and capabilities, and championing hyperlocal stories by connecting Singapore&#039;s media enterprises and talent to the world.</div><div><br></div><div>Ms Yvonne Tang, Assistant Chief Executive of IMDA&#039;s Media Industry Group, said: "New technologies and audience behaviours are constantly reshaping how we consume, distribute, and monetise content today. Our latest SMF 2026 programme is designed to help Singapore&#039;s media professionals and companies adapt in this evolving media landscape, by strengthening their creative and commercial capabilities through wide ranging partnerships and business opportunities."</div><div><br></div><div>Ms Tang added: "We also seek to reinforce Singapore&#039;s role as the heart of the world&#039;s stories by connecting local talent and stories with global expertise. We encourage our media professionals to take full advantage of the Festival and participate in its programmes, exchange ideas with industry peers and experts, and explore new avenues for collaboration and growth."</div><div><br></div><div>Discovering the Future of Asia&#039;s Creator Economy</div><div><br></div><div>ACS will take place from 4 to 5 December 2026 at Marina Bay Sands under the theme "Create. Monetise. Scale". Bringing together creators, creative entrepreneurs, brands, platforms, technology providers, and industry leaders, the two-day summit will comprise over 20 keynotes, panel discussions, master classes and hands-on sessions, focused on commercial opportunities and capability development to drive global visibility for Singapore&#039;s digital media industry.</div><div><br></div><div>Curated by Generation Experience (GenXP) together with Monica Khan, Founder and CEO of Creator Revolution, and developed in consultation with industry professionals, ACS will feature leading local and international creators and industry leaders sharing their journeys and the lessons behind their success. These include:</div><div>KIMPRO, one of South Korea&#039;s leading digital creators with over 130 million subscribers and 154 billion lifetime views;</div><div>ISSEI, one of Japan&#039;s leading digital creators with over 75 million YouTube subscribers, known for his engaging, non-verbal comedy content that has attracted audiences worldwide;</div><div>AJ Eckstein, Founder and CEO of US-based Creator Match that has helped brands such as Anthropic, Fiverr, Notion, Lovable and Zapier build and scale their creator programmes; and</div><div>Local personalities such as Johnathan Chua (CEO and Co-Founder, GRVTY Media), Kelvin Tan (CEO, DU Media Holdings), Althea Lim (Group CEO and Co-Founder, Gushcloud International).</div><div>Creators can also apply their creativity to real-world campaigns for leading brands. For instance, Mandarin Oriental, Singapore&#039;s Creator Pitch Challenge invites creators to develop an original content concept for its 40th Anniversary, while Bloomr.SG&#039;s "Creator Lab" pitching initiative will invite participants to pitch innovative, creator-focused ideas, with up to S$100,000 in awards up for grabs. The Call-for-Proposals (CFPs) open in early November 2026.</div><div><br></div><div>Ms Michelle Lim, Founder and CEO of GenXP, said: "Creators are playing an increasingly influential role in how audiences discover, engage and connect with content, brands and ideas. We are excited to launch Asia Creator Summit as part of the Singapore Media Festival, creating a platform for creators and the wider industry to learn from one another, share experiences and shape what comes next."</div><div><br></div><div>More information on ACS, including ticketing details and how to participate in the "Creator Lab", is available at www.asiacreatorsummit.com.</div><div><br></div><div>Building Asia&#039;s Stories Together</div><div><br></div><div>ATF, organised by RX Global, returns for its 27th edition at Marina Bay Sands from 1 to 4 December 2026 and is expected to bring together over 5,000 Asian and international content players from 60 countries and regions. Under the theme "The Attention Economy", the ATF Leaders&#039; Dialogue on 1 December 2026 will see senior industry representatives from East West Bank, Omdia, TikTok, Unilever, WEBTOON Productions, and YouTube discuss how evolving audience behaviour and fandom are reshaping content distribution, financing, and branded entertainment, and how businesses can turn audience engagement into commercial value.</div><div><br></div><div>ATF will introduce "The AI Era | Entertainment Reimagined", a dedicated programme and zone examining implications for content creation, intellectual property rights and regulation, including the protection of creative works. The programme will feature perspectives from Huace Group, Moonmax and Studio Meta K, alongside the Motion Picture Association, Television Academy and World Intellectual Property Organization. ATF will also host the Grand Finals of the AI Hackathon 2026, presented by Yoywow Space and Visify, featuring a live creative challenge and screenings of selected works.</div><div><br></div><div>On the market front, two new pavilions from Canada and Indonesia will expand ATF&#039;s international representation, offering buyers and potential partners access to a wider range of content and creative talent. Microdramas will receive growing attention at this year&#039;s market. ATF will continue to showcase exhibitors&#039; latest drama titles through its drama showcases, alongside accelerator and pitching programmes that spotlight emerging intellectual property and connect content producers with potential development partners.</div><div><br></div><div>Ms Yeow Hui Leng, Managing Director, Singapore of RX Global, said: "ATF has evolved beyond a marketplace to become a premier industry platform for strategic commercial announcements, content launches, and thought leadership from some of the entertainment industry&#039;s most influential voices. Emerging technology, including AI, will be a key part of this conversation, alongside critical issues such as regulation, financing, distribution, monetisation, and content innovation. This will give participants the insights needed to navigate an increasingly complex and dynamic global industry."</div><div><br></div><div>More information on ATF, including registration details, is available at www.asiatvforum.com.</div><div><br></div><div>Singapore Media Festival</div><div>The Singapore Media Festival, hosted by the Infocomm Media Development Authority (IMDA), proudly returns for its 13th edition as one of Asia&#039;s premier international media industry platforms. From 1 to 5 December 2026, Singapore will be the focal point for Asia&#039;s media community, showcasing diverse media innovations, forging industry deals, and presenting Singapore&#039;s world-class content. This year&#039;s festival, themed "The Heart of the World&#039;s Stories", aims to inspire the region&#039;s media talent to create, connect, and realise their visions. The event will bring together media professionals, industry leaders, creators, and consumers through the Asia Creator Summit and the Asia TV Forum & Market (ATF).</div><div><br></div><div>For more information, please visit: www.imda.gov.sg/smf.</div><div><br></div><div>Infocomm Media Development Authority</div><div>The Infocomm Media Development Authority ("IMDA") leads Singapore&#039;s digital transformation by developing a vibrant digital economy and an inclusive digital society. As Architects of Singapore&#039;s Digital Future, we foster growth in Infocomm Technology and Media sectors in concert with progressive regulations, harnessing frontier technologies, and developing local talent and digital infrastructure ecosystems to establish Singapore as a digital metropolis.</div><div><br></div><div>For more news and information, visit www.imda.gov.sg or follow IMDA on Facebook (IMDAsg) and Twitter (@IMDAsg).</div><div>The issuer is solely responsible for the content of this announcement.</div><div><br></div><div>Hashtags: #SingaporeMediaFestival #IMDA #AsiaTVForum #AsiaCreatorSummit</div><div><br></div><div>https://www.imda.gov.sg/</div>   ]]></description>
<pubDate>Wed, 21 Oct 2026 08:09:00 +0700</pubDate>
</item>
<item>
<title>Calcium-rich whey permeate improves bone health in postmenopausal women, study finds</title>
<link>https://relleaseid.com/berita-bisnis/Calcium-rich-whey-permeate-improves-bone-health-in-postmenopausal-women--study-finds</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/4698_Calcium-rich-whey-permeate-improves-bone-health-in-postmenopausal-women--study-finds.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>COPENHAGEN, Denmark, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Twice-daily supplementation with calcium-rich whey permeate supports the maintenance of bone mineral density in postmenopausal women, according to a 12-month clinical study.[1] Declining oestrogen levels during menopause can accelerate bone loss and reduce bone mineral density, increasing osteoporosis risk.</div><div><br></div><div>The findings come from the RENEW project, a research collaboration investigating how calcium-rich permeate from whey production could be used as a bioactive food ingredient to counteract bone loss in postmenopausal women.</div><div><br></div><div>A total of 316 women completed the study. Participants received either a placebo or 800mg of calcium per day from calcium carbonate or calcium-rich whey permeate (with or without inulin), divided into two daily doses. All participants also received vitamin D, which contributes to the maintenance of normal bones.</div><div><br></div><div>After 12 months, bone mineral density was maintained among women receiving calcium-rich whey permeate (n=78), while the placebo group (n=75) showed a reduction. Blood markers of bone turnover also indicated a noticeable slowing of bone loss by the third month. Adding inulin provided no additional bone health benefits.</div><div><br></div><div>The study used Arla Foods Ingredients&#039; Capolac, a calcium-rich milk-based ingredient, and Variolac, a lactose-based ingredient.</div><div><br></div><div>Simon B?ge Riis, Nutrition Scientist (PhD) at Arla Foods Ingredients, said: "Approximately one in five older adults globally has osteoporosis. It is especially common among postmenopausal women and across Asia, highlighting the need for effective nutritional strategies and the potential of calcium-rich whey permeate to support bone health."</div><div><br></div><div>Valorising calcium-rich whey permeate can support more efficient and sustainable whey production while creating opportunities for innovative food formats.</div><div><br></div><div>Arla Foods Ingredients is developing a dried fruit bar high in calcium, providing 265mg of calcium per 10g serving. The convenient format can be adapted to regional flavour preferences and incorporates solutions that help reduce fruit waste, supporting a more circular approach to food production.</div><div><br></div><div>Riis added: "Affordable calcium-rich milk-based ingredients could help address calcium deficiency, particularly in developing countries, and support food solutions targeting multiple nutritional deficiencies."</div><div><br></div><div>About the project</div><div><br></div><div>The RENEW study, conducted in Denmark and funded by Innovation Fund Denmark, is a partnership between Arla Foods Ingredients and leading academic institutions. It aims to develop an ingredient combining milk calcium, lactose-rich whey permeate and inulin, which may support calcium absorption.</div><div><br></div><div>View the research at: https://ajcn.nutrition.org/article/S0002-9165(26)00148-6/abstract</div><div><br></div><div>Reference:</div><div>[1] Tetens I, et al. Am J Clin Nutr. 2026;101339.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Wed, 21 Oct 2026 08:05:00 +0700</pubDate>
</item>
<item>
<title>BYD Energy Storage Mempercepat Perluasan Jaringan Layanan Purnajual BESS Global</title>
<link>https://relleaseid.com/berita-bisnis/BYD-Energy-Storage-Mempercepat-Perluasan-Jaringan-Layanan-Purnajual-BESS-Global</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/5839_BYD-Energy-Storage-Mempercepat-Perluasan-Jaringan-Layanan-Purnajual-BESS-Global.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>SHENZHEN, Tiongkok, Oct. 20, 2026 (GLOBE NEWSWIRE) -- BYD Energy Storage telah membangun jaringan layanan purnajual komprehensif dengan kerangka multi-tingkat: operasional dan pemeliharaan (O&M) stasiun, pusat proyek, pusat regional, dan kantor pusat global.</div><div><br></div><div>BYD Energy Storage mengoperasikan sembilan O&M di seluruh dunia, yang masing-masing memiliki luas 2.500 meter persegi. Jaringan layanan purnajualnya mencakup Tiongkok, Cile, Afrika Selatan, Inggris Raya, AS, Australia, Jepang, Polandia, dan Timur Tengah. </div><div><br></div><div>Pusat layanan baru akan dibuka di Afrika Selatan dan Bulgaria pada tahun 2027 untuk semakin memperluas jangkauan layanan globalnya. Pusat-pusat layanan itu menjalankan berbagai fungsi utama, termasuk penyimpanan dan pengelolaan suku cadang, perbaikan dan pemeliharaan baterai, alokasi suku cadang regional, daur ulang baterai, serta pelatihan bagi insinyur yang direkrut secara lokal.</div><div><br></div><div>Pusat-pusat regional BYD Energy Storage beroperasi dengan sepenuhnya mematuhi ketentuan peraturan setempat, menyediakan pelatihan tenaga kerja yang terstruktur, serta memastikan respons cepat langsung di lokasi. </div><div><br></div><div>Tim layanan profesional itu terdiri atas lebih dari 200 insinyur lapangan dan lebih dari 100 spesialis Litbang. Perusahaan menerapkan standar perjanjian tingkat layanan (SLA) yang seragam: dengan ketentuan waktu respons dalam 24 jam, kedatangan di lokasi dalam 48 jam, serta penanganan masalah dalam 7 hari.</div><div><br></div><div>Jaringan layanan global perusahaan telah memiliki jangkauan luas. Jaringan ini membentuk sistem pasokan yang tersebar di berbagai lokasi untuk memastikan pengiriman suku cadang secara cepat ke seluruh dunia. Selain itu, dengan memanfaatkan lini produksi lokal, tim O&M perusahaan mengintegrasikan sumber daya regional untuk menyediakan layanan perbaikan baterai di wilayah setempat. Dengan demikian, pelanggan di seluruh dunia dapat memperoleh dukungan purnajual yang cepat, mudah diakses, dan tersedia secara lokal.</div><div><br></div><div>"Jangkauan layanan global kami disesuaikan dengan pesatnya pertumbuhan penerapan sistem penyimpanan energi baterai (BESS). Dukungan purna jual tepercaya menunjang pengoperasian aset penyimpanan energi yang stabil dalam jangka panjang," ujar He Dehong, Head of Global After-sales Service di BYD Energy Storage.</div><div><br></div><div>Dengan mengusung visi untuk memberdayakan industri penyimpanan energi global melalui layanan digital dan cerdas, sistem O&M global BYD Energy Storage yang telah matang memberikan dukungan kuat bagi perluasan jangkauan sistem penyimpanan energi baterainya. </div><div><br></div><div>Perusahaan menempati posisi teratas dalam pengiriman BESS global pada tahun 2025 dengan volume lebih dari 60 GWh, serta telah melaksanakan lebih dari 650 proyek penyimpanan energi secara keseluruhan. Pencapaian ini didukung oleh layanan purnajual yang terstandardisasi dan tersedia secara lokal guna memastikan pengoperasian aset yang andal.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Wed, 21 Oct 2026 07:59:00 +0700</pubDate>
</item>
<item>
<title>MPL Indonesia Welcomes AIMS as Official Trading Partner for Season 18</title>
<link>https://relleaseid.com/berita-bisnis/MPL-Indonesia-Welcomes-AIMS-as-Official-Trading-Partner-for-Season-18</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/560_MPL-Indonesia-Welcomes-AIMS-as-Official-Trading-Partner-for-Season-18.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>JAKARTA, INDONESIA - EQS Newswire - 20 October 2026 - Mobile Legends: Bang Bang Professional League Indonesia (MPL Indonesia) welcomes AIMS as its Official Trading Partner for MPL Indonesia Season 18, marking another milestone in the league&#039;s growing and increasingly diverse partnership ecosystem.</div><div><br></div><div>The collaboration brings AIMS into one of Indonesia&#039;s most established esports communities, connecting the global Forex and CFD broker with MLBB fans through community engagement, education, digital initiatives and selected offline activations throughout Season 18.</div><div><br></div><div>MPL Indonesia Season 18 is currently underway, with the Regular Season running from 14 August to 18 October 2026. (MPL Indonesia Season 18)</div><div><br></div><div>Mr. Martinus H. Manurung, Head of Esports Business Development, MOONTON Games Indonesia, said:</div><div><br></div><div>"Welcoming AIMS reflects the continued growth and diversification of the MPL Indonesia partnership ecosystem. It is encouraging to see brands from new industries recognising the strength of MLBB esports, the passion of our community and the value of being part of this platform."</div><div><br></div><div>"The confidence shown by both new and long-standing partners continues to strengthen the ecosystem around MPL Indonesia. We are pleased to welcome AIMS for Season 18 and look forward to seeing how they engage with our community in a relevant, responsible and enjoyable way."</div><div><br></div><div>From Grind to Pro</div><div>At the heart of the partnership is a shared belief that progress takes discipline, learning, teamwork and consistency.</div><div><br></div><div>Whether developing as an individual or competing as part of a team, becoming better requires preparation, patience, trust in others and a willingness to continuously improve.</div><div><br></div><div>AIMS sees the same values in trading education and personal development, where understanding the fundamentals, making informed decisions and maintaining discipline are essential parts of long-term progress.</div><div><br></div><div>The strength of the wider MPL Indonesia ecosystem also played an important role in AIMS&#039; decision to join. The continued involvement of established brands and long-standing partners demonstrates the confidence businesses place in MPL and the community built around it.</div><div><br></div><div>Mr. Rudy Hermanto, Marketing Manager, AIMS International, said:</div><div><br></div><div>"We believe in MLBB and MPL as a healthy competitive esports ecosystem that brings people together. Whether you are improving individually or competing as a team, becoming better requires discipline, patience, learning and strong fundamentals."</div><div><br></div><div>"Those values resonate strongly with us at AIMS. Through this partnership, we want to provide an educational platform where the community can have fun, compete and connect, while also learning about responsible trading, discipline and financial market fundamentals."</div><div><br></div><div>"We have also seen the commitment that many established brands and partners have shown towards MPL Indonesia over the years. That gave us further confidence that this is an ecosystem worth being part of and contributing to."</div><div><br></div><div>Bringing Grind to Pro to the MPL Community</div><div>Throughout MPL Indonesia Season 18, AIMS will introduce its Grind to Pro platform through selected community, digital and offline initiatives.</div><div><br></div><div>The programme will connect community participation, educational content, social activations and creator engagement with the shared values of discipline, teamwork and continuous improvement.</div><div><br></div><div>The objective is to build a partnership that goes beyond visibility, giving the MPL community meaningful ways to engage with AIMS throughout the season.</div><div><br></div><div>MOONTON has previously highlighted how partnerships can extend beyond traditional sponsorship exposure into community programmes and fan experiences, including initiatives involving tournaments, education and onsite activations. (Moonton)</div><div><br></div><div>A New Partnership Milestone</div><div>AIMS joining MPL Indonesia as its Official Trading Partner for Season 18 adds another category to the league&#039;s expanding commercial ecosystem.</div><div><br></div><div>More importantly, the partnership is not simply symbolic. It is the result of strategic discussions around how esports can create opportunities for education, community building and meaningful engagement with Indonesia&#039;s digitally connected generation.</div><div><br></div><div>For AIMS, the partnership represents an opportunity to become part of an established ecosystem built around competition, entertainment and community.</div><div><br></div><div>For MPL Indonesia, it marks another step in broadening the range of industries and partners participating in the MLBB esports ecosystem.</div><div><br></div><div>A new partner, a new category and another milestone for MPL Indonesia Season 18.</div><div><br></div><div>Regulatory Note</div><div>Trading in leveraged financial products involves risk and may not be suitable for everyone. Any trading-related education, promotion or customer acquisition conducted under this partnership remains subject to applicable Indonesian regulations and AIMS&#039; internal compliance requirements.</div><div><br></div><div>About AIMS</div><div>AIMS (Auric International Markets) is a renowned global financial brokerage offering institutional-grade execution, clearing services, and multi-asset technology for retail and institutional clients worldwide. Established in 2015, AIMS operates a powerhouse footprint across more than 21 countries, supported by foundational regional hubs spanning Europe, Asia, and the Middle East.</div><div><br></div><div>About MPL Indonesia</div><div>Mobile Legends: Bang Bang Professional League Indonesia is Indonesia&#039;s professional MLBB esports league, bringing together professional teams, players, fans, communities and brand partners through one of the country&#039;s leading esports competitions.</div><div><br></div><div>About MOONTON Games</div><div>Established in 2014, MOONTON is a global video game company dedicated to gaming development, publication, and esports. With more than 2,000 employees worldwide, the company operates offices in China, Indonesia, Malaysia, the Philippines, and Singapore. It has successfully launched several high-profile mobile games globally and has built long-term relationships with governments and esports organizations in more than 30 countries around the world. Mobile Legends: Bang Bang is its current star game and the leading mobile multiplayer online battle arena (MOBA) game worldwide.</div><div><br></div><div>About Mobile Legends: Bang Bang</div><div>Mobile Legends: Bang Bang is one of the most popular mobile Multiplayer Online Battle Arena (MOBA) games worldwide that brings communities together through teamwork and strategy. With over 1.5 billion installations and 110 million active monthly users, the award-winning game is among the top 10 most played in over 80 countries. With an extensive reach across the Asia Pacific region, the multiplayer is available in 139 countries with an expansive global esports presence.</div><div><br></div><div>The issuer is solely responsible for the content of this announcement.</div><div><br></div><div>Hashtags: #MPLIndonesia #AIMS #MLBB</div>   ]]></description>
<pubDate>Wed, 21 Oct 2026 07:04:00 +0700</pubDate>
</item>
<item>
<title>Scenic Group Marks 40 Years with Global River &amp; Yacht Expansion</title>
<link>https://relleaseid.com/berita-bisnis/Scenic-Group-Marks-40-Years-with-Global-River--amp--Yacht-Expansion</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/4202_Scenic-Group-Marks-40-Years-with-Global-River--amp--Yacht-Expansion.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>SINGAPORE - Media OutReach Newswire - 20 October 2026 - Scenic Group marks its 40th anniversary this October with guest and partner celebrations worldwide, alongside a programme of river and yacht expansion through 2028 and beyond.</div><div><br></div><div>The milestone comes as the Group prepares to introduce new luxury Scenic and Emerald Cruises river ships in Europe, India and Southeast Asia, expand the Emerald Yacht Cruises fleet and debut Scenic Ikon.</div><div><br></div><div>Scenic Group Founder & Chairman Glen Moroney said: "From our beginnings in Australia in 1986, we have grown into a global travel group spanning all seven continents. Throughout that growth, our vision has remained the same: to continually elevate how our guests experience the world.</div><div><br></div><div>"Guest feedback drives our innovation and guides our investment in new ships, destinations and journeys. Designing, building, owning and operating our own fleet gives us greater control over the guest experience and the ability to translate those insights into new benchmarks in luxury cruising.</div><div><br></div><div>"This anniversary is an opportunity to thank our valued guests, partners, crew and teams around the world who have shaped Scenic Group&#039;s success. As we look ahead, we remain focused on delivering experiences that build on everything we have learned over the past 40 years, with many more exciting new developments on the horizon."</div><div><br></div><div>The next chapter: new ships and destinations</div><div><br></div><div>Scenic Group&#039;s expansion programme will extend its presence across Europe&#039;s rivers, India and Southeast Asia, and worldwide yacht cruising.</div><div><br></div><div>In France, Emerald Lumi will expand Emerald Cruises & Tours&#039; river cruise offering on the Seine River in 2027. Scenic&#039;s growth in Asia will introduce journeys on India&#039;s Hooghly River in 2027, with a further ship planned for the Brahmaputra River in 2028.</div><div><br></div><div>Scenic Spirit II and Scenic Spirit III will also launch on the Mekong River in 2028, further elevating the Group&#039;s ultra-luxury ships in Southeast Asia.</div><div><br></div><div>The luxury yacht expansion includes Emerald Raiya in 2027 and Emerald Xara in 2028. These additions will broaden Emerald Cruises&#039; destination offering, including the Seychelles.</div><div><br></div><div>Scenic Eclipse II&#039;s return to Asia Pacific in 2028, alongside Emerald Xara&#039;s arrival, will further strengthen the Group&#039;s presence in the region.</div><div><br></div><div>Scenic Ikon will debut in the Mediterranean in April 2028, with Antarctica also featuring in its inaugural season, marking the next chapter in the Scenic Discovery Yachts ultra-luxury collection.</div><div><br></div><div>Anniversary celebrations throughout October</div><div><br></div><div>Guests travelling with Scenic and Emerald Cruises & Tours throughout October are enjoying special dining events, themed entertainment and commemorative experiences.</div><div><br></div><div>Selected Scenic & Emerald Rewards loyalty departures have also been planned for the anniversary month. These include the annual Scenic Discovery Yachts Chairman&#039;s Voyage in the United States, featuring special events in Wilmington, Charleston and Key West, and a Scenic Romantic Rhine & Moselle river cruise with a Switzerland land extension and an exclusive dinner in Lucerne hosted by Scenic Group management.</div><div><br></div><div>Tom Goetter, VP Oceans Hotel Operations, said "These moments are an opportunity to share the Scenic Group story with our guests and recognise the people, care and attention to detail behind every journey."</div><div><br></div><div>For more information on Scenic and Emerald Cruises & Tours, visit www.scenictoursapac.com.sg</div><div><br></div><div>About Scenic Group</div><div>For 40 years, Scenic Group has set the benchmark for innovation in luxury travel, creating award-winning river and ocean cruises and handcrafted land journeys. Beginning in Australia in 1986, the company has grown into a global leader through its brands: Scenic Luxury Cruises & Tours & Emerald Cruises & Tours.</div><div><br></div><div>Scenic Group is the only cruise company to design, build, crew and operate its own ships with the expertise of its in-house shipbuilding division. This fully integrated model ensures exceptional quality and a consistently elevated guest experience.</div><div><br></div><div> With a strong global footprint and high repeat guest rates, Scenic and Emerald Cruises are uniquely positioned to deliver seamless, end-to-end journeys across ocean and river cruises and land tours under each of the three brands.</div><div><br></div><div>The issuer is solely responsible for the content of this announcement.</div><div><br></div><div>Hashtags: #ScenicGroup #ScenicCruises #EmeraldCruises #ScenicDiscoveryYachts #Scenicikon #ScenicEclipse</div><div><br></div><div>https://www.scenictoursapac.com.sg</div>   ]]></description>
<pubDate>Wed, 21 Oct 2026 07:00:00 +0700</pubDate>
</item>
<item>
<title>SCG Shares Perspectives on Innovation and AI at the Forbes Global CEO Conference 2026, Highlighting New Ways of Working for a Fast-Changing Business World</title>
<link>https://relleaseid.com/berita-bisnis/SCG-Shares-Perspectives-on-Innovation-and-AI-at-the-Forbes-Global-CEO-Conference-2026--Highlighting-New-Ways-of-Working-for-a-Fast-Changing-Business-World</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/7823_SCG-Shares-Perspectives-on-Innovation-and-AI-at-the-Forbes-Global-CEO-Conference-2026--Highlighting-New-Ways-of-Working-for-a-Fast-Changing-Business-World.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>SCG Shares Perspectives on Innovation and AI at the Forbes Global CEO Conference 2026, Highlighting New Ways of Working for a Fast-Changing Business World</div><div><br></div><div>SINGAPORE - Media OutReach Newswire - 20 October 2026 - Mr. Thammasak Sethaudom, President and CEO of SCG, took part in a panel discussion at the Forbes Global CEO Conference 2026, a global forum, under the theme "Faster Turns, Breaking Limits," alongside business leaders from a wide range of industries.</div><div><br></div><div> He stated that, amid rapid change, long-term business growth requires the adoption of innovation, automation and technology across both business operations and ways of working in order to enhance competitiveness. He cited Low Carbon Cement as an example, where low-carbon innovation and technology have been applied to strengthen the competitiveness of Thailand&#039;s cement industry and to meet customers&#039; demand for green products.</div><div><br></div><div>The Forbes Global CEO Conference is an annual gathering of business leaders, investors and thought leaders from around the world to exchange views on the economy, business trends and opportunities for international collaboration. This year&#039;s conference was held in Singapore on 7?8 October 2026, with SCG among the representatives of the Thai business community in attendance.</div><div><br></div><div>Mr. Thammasak said, "The rapid pace of change in the business world requires organizations to adapt in terms of technology, mindset and ways of working. Innovation is not limited to adopting new technologies; it also means adjusting working models to suit the circumstances so that teams can think, decide and act together more quickly. One example is Low Carbon Cement, for which SCG has combined external knowledge with in-house research to accelerate development and scale-up to commercial production. This responds to customers&#039; demand for green products and enhances the competitiveness of the domestic cement industry. Development has also begun in Vietnam, with plans to expand to Indonesia."</div><div><br></div><div>At the Forbes Global CEO Conference 2026, SCG exchanged views with business leaders from various industries in China and India who joined the panel on "Faster Turns, Breaking Limits." The discussion covered innovation, AI and technology, as well as adapting mindsets and ways of working to keep pace with a changing business landscape and with competition across ASEAN.</div><div>The issuer is solely responsible for the content of this announcement.</div><div><br></div><div>Hashtags: #SCG</div><div><br></div>   ]]></description>
<pubDate>Wed, 21 Oct 2026 06:55:00 +0700</pubDate>
</item>
<item>
<title>CNH to announce 2026 Q3 results on November 9</title>
<link>https://relleaseid.com/berita-bisnis/CNH-to-announce-2026-Q3-results-on-November-9</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/6352_CNH-to-announce-2026-Q3-results-on-November-9.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>Basildon, UK - October 19, 2026 - CNH (NYSE: CNH) will release its financial results for the Third Quarter of 2026 on Monday, November 9, 2026.&nbsp;&nbsp;</div><div><br></div><div>A live listen-only webcast of the financial results conference call will begin at 9:00 a.m. ET on the same day here: https://events.q4inc.com/attendee/972547137</div><div><br></div><div>For those unable to participate in the live session, a replay will remain archived in the Investor Relations section of the corporate website (www.cnh.com) for 12 months.&nbsp;</div><div><br></div><div>Dial-in details:&nbsp;</div><div><br></div><div>Those interested in participating in the Q&A session should connect via telephone at least 10 minutes prior to the start of the event. Telephone participants are required to register in advance via the following link: https://events.q4inc.com/analyst/972547137?pwd=Hsf7bzsZ</div><div><br></div><div>After registration, participants will receive dial&#8209;in instructions by email, including:&nbsp;</div><div><br></div><div>the conference call dial&#8209;in number&nbsp;</div><div>the meeting ID (972547137)&nbsp;</div><div>a unique passcode to access the call&nbsp;</div><div>***</div><div><br></div><div>About CNH</div><div><br></div><div>CNH (NYSE: CNH) serves and advances the people who feed and build a growing world.</div><div><br></div><div>We are an iron-and-tech company, engineering intelligence, automation, and precision into the machines that move the global economy. Our equipment operates in more than 160 markets, supported by a global team of more than 34,000 people, including engineers, technologists, and industry experts.</div><div><br></div><div>Our brands - Case IH, New Holland, and STEYR in agriculture; CASE Construction Equipment and New Holland Construction in building - are backed by CNH Capital and complemented by a portfolio of technology and regional brands that together generated $18.1B in revenue in 2025.</div><div><br></div><div>Building on a legacy of innovation dating back to 1842, CNH has achieved milestones including the first mass-produced tractor, the first twin-rotor combine, and the first factory-integrated precision farming system.</div><div><br></div><div>Today, we are engineering autonomous and predictive machines that will shape the future of food and infrastructure.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Wed, 21 Oct 2026 06:46:00 +0700</pubDate>
</item>
<item>
<title>Fortrea Completes Acquisition of the Early Phase Services Division from Worldwide Clinical Trials</title>
<link>https://relleaseid.com/berita-bisnis/Fortrea-Completes-Acquisition-of-the-Early-Phase-Services-Division-from-Worldwide-Clinical-Trials</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/8871_Fortrea-Completes-Acquisition-of-the-Early-Phase-Services-Division-from-Worldwide-Clinical-Trials.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>Expands Fortrea&#039;s early clinical development network with dedicated bioanalytical capabilities, increased clinical research unit capacity and a more integrated platform for clients</div><div><br></div><div>Highlights:</div><div><br></div><div>*Fortrea completes acquisition of the Early Phase Services division from Worldwide Clinical Trials</div><div>*Adds a 60,000-square-foot GLP-compliant bioanalytical laboratory in Austin, Texas; a 200-bed GCP-compliant clinical pharmacology unit in San Antonio, Texas; and a biospecimen storage facility in Pflugerville, Texas</div><div>*Expands Fortrea&#039;s early clinical development capacity to more than 570 beds globally and adds dedicated large and small molecule bioanalytical capabilities</div><div>*Enables more integrated execution of early-phase studies by reducing operational handoffs between clinical and bioanalytical functions</div><div>*Strengthens Fortrea&#039;s end-to-end clinical development platform supporting clients from first-in-human studies through Phase IV and post-approval evidence generation</div><div>*Supports Fortrea&#039;s growth strategy by scaling early clinical development capabilities, increasing clinical research unit capacity and enhancing the company&#039;s ability to create long-term value for shareholders</div><div>*Provides continuity of operations, study delivery and client support throughout the transition through a strategic alliance agreement between the companies</div><div><br></div><div>DURHAM, N.C., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the "Company"), a leading global contract research organization ("CRO"), today announced it has completed its acquisition of the Early Phase Services division from Worldwide Clinical Trials. The division consists of a Clinical Research Unit ("CRU") and Bioanalytical Laboratory operations, in an all-cash transaction valued at approximately $45 million.</div><div><br></div><div>The acquisition strengthens Fortrea&#039;s end-to-end clinical development platform by adding a 200-bed Good Clinical Practice-compliant CRU in San Antonio, Texas; a 60,000-square-foot Good Laboratory Practice-compliant bioanalytical laboratory in Austin, Texas; and a biospecimen storage facility in Pflugerville, Texas. Together, these assets expand Fortrea&#039;s early-phase capacity to more than 570 beds globally and add in-house large and small molecule bioanalytical capabilities to support clients from first-in-human studies through proof-of-concept and later-stage development.</div><div><br></div><div>"Completing this acquisition further strengthens our integrated, scalable and scientifically differentiated clinical development platform," said Anshul Thakral, CEO of Fortrea. "This transaction demonstrates tangible progress in Fortrea&#039;s return to growth as we invest in our ability to win new opportunities and create lasting value for clients. By bringing together complementary clinical pharmacology and bioanalytical capabilities, we expect to expand the speed, flexibility and talent we can offer clients as they advance increasingly complex development programs. We are pleased to welcome the Early Phase Services team to Fortrea and look forward to delivering a seamless experience for clients, volunteers and the patients we ultimately serve."</div><div><br></div><div>"With this investment, Fortrea adds capability and capacity in its commitment to help clients design and execute early development programs with greater speed, scientific rigor and operational connectivity," said Scott Dove, Ph.D., president, Clinical Pharmacology Services at Fortrea. "The addition of dedicated bioanalytical capabilities and expanded CRU capacity gives our teams more ways to support both simple and complex studies, streamline execution and generate high-quality data that inform development decisions."</div><div><br></div><div>The addition of these capabilities complements Fortrea&#039;s existing Clinical Pharmacology Services business and broadens its North American CRU footprint. The combined platform is designed to reduce operational handoffs between clinical and bioanalytical functions, improve turnaround times and provide clients with greater flexibility for complex and larger participant studies, broader access to distinct volunteer populations and expanded bedspace capacity across Fortrea&#039;s early development network.</div><div><br></div><div>Fortrea and Worldwide Clinical Trials have also entered into agreements intended to support continuity for clients, employees and ongoing programs. Both organizations remain focused on maintaining project momentum and providing a seamless transition for employees, clients and volunteers.</div><div><br></div><div>The acquired Early Phase Services operations are now part of Fortrea&#039;s Clinical Pharmacology Services business unit.</div><div><br></div><div>Advisors</div><div>Barclays served as financial advisor to Fortrea, and Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. served as its legal counsel.</div><div><br></div><div>About Fortrea</div><div><br></div><div>Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. </div><div><br></div><div>Fortrea&#039;s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to clients globally. Learn more about how Fortrea is streamlining drug development at Fortrea.com and follow us on LinkedIn, X and Bluesky.</div><div><br></div><div>Cautionary Statement Regarding Forward-Looking Statements</div><div><br></div><div>This press release contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the anticipated benefits of the transaction, including future financial and operating performance, and the anticipated timing for completing the transaction. </div><div><br></div><div>In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "guidance," "expect," "assume," "anticipate," "intend," "plan," "forecast," "believe," "seek," "see," "will," "would," "target," similar expressions, and variations or negatives of these words that are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. </div><div><br></div><div>Actual results could differ materially from these forward looking statements due to a number of factors, including, but not limited to:&nbsp; the parties&#039; ability to meet expectations regarding the accounting and tax treatments of the proposed transaction; the anticipated benefits of the acquisition may not be realized, or may be realized more slowly or to a lesser extent than expected, difficulties, delays, costs or disruptions associated with integrating the acquired business, operations, employees, systems and processes into the Company, the ability to retain existing customers and business relationships of the acquired operations and win new business following the acquisition, the ability to retain and integrate key employees of the acquired business, the parties&#039; ability to perform their respective obligations under transition services and other agreements, unanticipated liabilities, expenses or adverse effects associated with the acquired business, the ability to maintain applicable regulatory, quality and accreditation requirements for the acquired sites, and other factors described from time to time in documents that the Company files with the SEC. </div><div><br></div><div>For a further discussion of the risks relating to the Company&#039;s business, see the "Risk Factors" Section of the Company&#039;s most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q, as filed with the Securities and Exchange Commission (the "SEC"), as such factors may be amended or updated from time to time in the Company&#039;s subsequent periodic and other filings with the SEC, which are accessible on the SEC&#039;s website at www.sec.gov. </div><div><br></div><div>These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included or incorporated by reference in this report and in the Company&#039;s filings with the SEC. All forward-looking statements are made only as of the date of this report and the Company does not undertake any obligation, other than as may be required by law, to update or revise any forward-looking statements to reflect future events or developments.&nbsp;</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Wed, 21 Oct 2026 06:40:00 +0700</pubDate>
</item>
<item>
<title>Logos Launches at Money20/20 USA to Help Financial Institutions Build New Business with Tokenized Assets and Stablecoins</title>
<link>https://relleaseid.com/berita-bisnis/Logos-Launches-at-Money20-20-USA-to-Help-Financial-Institutions-Build-New-Business-with-Tokenized-Assets-and-Stablecoins</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/9826_Logos-Launches-at-Money20-20-USA-to-Help-Financial-Institutions-Build-New-Business-with-Tokenized-Assets-and-Stablecoins.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>Founded by former Swift and Matter Labs Executives and Backed by ParaFi and VanEck, Logos Launches its Testnet with Initial Design Partners Paysend and Securitize</div><div><br></div><div>LAS VEGAS, Oct. 19, 2026 (GLOBE NEWSWIRE) -- LogosFi, Inc. ("Logos") today launched at Money20/20 USA to help financial institutions expand the business they can do with tokenized assets and stablecoins. For custodians, that means more assets to service. For lenders, a broader range of eligible collateral. </div><div><br></div><div>For payment institutions, more settlement options to support customer flows. Logos is building the shared evidence infrastructure that helps institutions establish which of these opportunities they can pursue and under what conditions.</div><div><br></div><div>Each new asset or use requires evidence of rights, backing, custody and restrictions. Today, institutions repeatedly assemble the same evidence. Logos makes it discoverable, verifiable and reusable, helping institutions expand their offerings without rebuilding the evidence base for every relationship.</div><div><br></div><div>Logos also announced today the availability of its testnet with initial design partners Paysend and Securitize. The company is targeting its first production workflows for early 2027.</div><div><br></div><div>The company was founded by Tom Zschach, former Chief Innovation Officer at Swift, and Anthony Rose, former CTO of Matter Labs, the company behind ZKsync. Zschach serves as CEO and Rose as CTO. The company is backed by ParaFi, VanEck and strategic investors.</div><div><br></div><div>"Every institution that can put an asset to work expands its potential market," said Zschach. "Our principle is simple: Publish once. Verify anywhere. Evidence should support the next commercial relationship without everyone starting again."</div><div><br></div><div>Paysend is helping shape payment and settlement workflows, while Securitize is helping shape workflows for tokenized securities.</div><div><br></div><div>"Stablecoins will only scale when institutions can trust what they&#039;re accepting. We are excited to partner with Logos to continue building the stablecoin-based backbone of our network, comfortable that we will be scaling our trust and our growth hand in hand," said Ben Chisell, Group CEO of Paysend.</div><div><br></div><div>"One of the biggest opportunities in tokenization is making it easier for financial institutions to support these assets within their existing systems," said Carlos Domingo, Chairman and CEO of Securitize. "By making information about Securitize&#039;s tokenized products accessible through Logos, we&#039;re helping simplify how custodians, brokers and other institutions integrate these assets into their platforms. We&#039;re excited to support infrastructure that can help bring tokenized securities to more institutions and investors."</div><div><br></div><div>Through an API, institutions can retrieve evidence, verify it against specified requirements and retain a record of what they relied on. Monitoring identifies changes within agreed source coverage.</div><div><br></div><div>Evidence remains attributable to its sources, while each institution retains its own policies, compliance systems, valuation and acceptance decisions.</div><div><br></div><div>Logos is also engaging with Solana Foundation, Ethereum Institutional, Consensys, Hashgraph, Avalanche, Fireblocks, Cyfrin, Halborn and GLEIF on evidence requirements for institutional acceptance.</div><div><br></div><div>Logos is opening ten receiver design partnerships for custodians, lenders and payment institutions with a specific commercial use on their roadmap. Participants will help shape evidence coverage and interfaces for the first production workflows, supported directly by the Logos team.</div><div><br></div><div>Institutions interested in participating can visit logosfi.com or contact hello@logosfi.com.</div><div><br></div><div>About Logos</div><div>LogosFi, Inc. builds shared evidence infrastructure for financial institutions using tokenized assets, stablecoins and digital money. It makes evidence reusable while preserving source attribution and each institution&#039;s policy, judgment and accountability.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Wed, 21 Oct 2026 06:37:00 +0700</pubDate>
</item>
<item>
<title>Logos Resmi Diluncurkan di Money20/20 USA untuk Membantu Lembaga Keuangan Membangun Bisnis Baru dengan Aset yang Ditokenisasi dan Stablecoin</title>
<link>https://relleaseid.com/berita-bisnis/Logos-Resmi-Diluncurkan-di-Money20-20-USA-untuk-Membantu-Lembaga-Keuangan-Membangun-Bisnis-Baru-dengan-Aset-yang-Ditokenisasi-dan-Stablecoin</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/4351_Logos-Resmi-Diluncurkan-di-Money20-20-USA-untuk-Membantu-Lembaga-Keuangan-Membangun-Bisnis-Baru-dengan-Aset-yang-Ditokenisasi-dan-Stablecoin.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>Didirikan oleh Mantan Eksekutif Swift dan Matter Labs serta Didukung oleh ParaFi dan VanEck, Logos Meluncurkan Testnet dengan Paysend dan Securitize sebagai Mitra Desain Awal</div><div><br></div><div>LAS VEGAS, Oct. 20, 2026 (GLOBE NEWSWIRE) -- LogosFi, Inc. ("Logos") hari ini resmi diluncurkan di Money20/20 USA untuk membantu lembaga keuangan memperluas bisnis yang dapat mereka jalankan dengan memanfaatkan aset yang ditokenisasi dan stablecoin. </div><div><br></div><div>Bagi penyedia layanan kustodian, hal ini berarti lebih banyak aset yang dapat mereka layani. Bagi pemberi pinjaman, hal ini berarti pilihan agunan yang memenuhi syarat menjadi lebih luas. </div><div><br></div><div>Bagi lembaga pembayaran, hal ini berarti lebih banyak pilihan penyelesaian transaksi untuk mendukung arus transaksi pelanggan. Logos tengah membangun infrastruktur bukti bersama yang membantu lembaga keuangan menentukan peluang mana yang dapat mereka tindak lanjuti serta persyaratan yang harus dipenuhi.</div><div><br></div><div>Setiap aset baru atau penggunaannya memerlukan bukti terkait hak, dukungan aset, penyimpanan oleh penyedia layanan kustodian, serta pembatasan yang berlaku. Saat ini, lembaga-lembaga keuangan harus berulang kali mengumpulkan bukti yang sama. Logos memungkinkan bukti tersebut ditemukan, diverifikasi, dan digunakan kembali sehingga membantu lembaga keuangan memperluas penawarannya tanpa perlu menyusun ulang kumpulan bukti pendukung untuk setiap hubungan bisnis.</div><div><br></div><div>Hari ini, Logos juga mengumumkan bahwa testnet-nya telah tersedia, dengan Paysend dan Securitize sebagai mitra desain awal. Perusahaan menargetkan penerapan alur kerja produksi pertamanya pada awal tahun 2027.</div><div><br></div><div>Perusahaan ini didirikan oleh Tom Zschach, mantan Chief Innovation Officer di Swift, dan Anthony Rose, mantan CTO di Matter Labs, perusahaan di balik ZKsync. Zschach menjabat sebagai CEO, sedangkan Rose sebagai CTO. Perusahaan ini didukung oleh ParaFi, VanEck, dan sejumlah investor strategis.</div><div><br></div><div>"Setiap lembaga keuangan yang mampu memanfaatkan suatu aset dapat memperluas peluang pasarnya," ujar Zschach. "Prinsip kami sederhana: Publikasikan sekali. Verifikasi di mana saja. Bukti seharusnya dapat mendukung hubungan bisnis selanjutnya tanpa mengharuskan semua pihak mengulang proses dari awal."</div><div><br></div><div>Paysend turut membantu membentuk alur kerja pembayaran dan penyelesaian transaksi, sedangkan Securitize turut membantu membentuk alur kerja untuk sekuritas yang ditokenisasi.</div><div><br></div><div>"Penggunaan stablecoin hanya dapat berkembang jika lembaga keuangan dapat memercayai aset yang mereka terima. Kami senang dapat bermitra dengan Logos untuk terus membangun fondasi jaringan kami yang berbasis stablecoin, dengan keyakinan bahwa peningkatan kepercayaan dan pertumbuhan bisnis kami dapat berjalan beriringan," ujar Ben Chisell, CEO Grup Paysend.</div><div><br></div><div>"Salah satu peluang terbesar dalam tokenisasi adalah mempermudah lembaga keuangan untuk mendukung aset-aset tersebut melalui sistem yang sudah mereka gunakan," ujar Carlos Domingo, Chairman dan CEO Securitize. "Dengan membuat informasi mengenai produk Securitize yang ditokenisasi dapat diakses melalui Logos, kami membantu menyederhanakan cara penyedia layanan kustodian, broker, dan lembaga keuangan lainnya mengintegrasikan aset-aset tersebut ke dalam platform mereka. Kami senang dapat mendukung infrastruktur yang dapat membantu memperluas akses terhadap sekuritas yang ditokenisasi bagi lebih banyak lembaga keuangan dan investor."</div><div><br></div><div>Melalui API, lembaga keuangan dapat memperoleh bukti, memverifikasinya berdasarkan persyaratan yang ditetapkan, serta menyimpan data mengenai bukti yang mereka jadikan dasar. Pemantauan mengidentifikasi perubahan dalam cakupan sumber yang telah disepakati.</div><div><br></div><div>Bukti tetap dapat ditelusuri ke sumbernya masing-masing, sedangkan setiap lembaga keuangan tetap mempertahankan kebijakan, sistem kepatuhan, penilaian, dan keputusan penerimaannya sendiri.</div><div><br></div><div>Logos juga menjalin komunikasi dengan Solana Foundation, Ethereum Institutional, Consensys, Hashgraph, Avalanche, Fireblocks, Cyfrin, Halborn, dan GLEIF mengenai persyaratan bukti untuk penerimaan oleh lembaga keuangan.</div><div><br></div><div>Logos membuka kesempatan untuk menjalin sepuluh kemitraan desain dengan lembaga penerima bagi penyedia layanan kustodian, pemberi pinjaman, dan lembaga pembayaran yang memiliki rencana penggunaan komersial tertentu dalam peta jalan mereka. Para peserta akan turut membantu membentuk cakupan bukti dan antarmuka untuk alur kerja produksi pertama, yang didukung langsung oleh tim Logos.</div><div><br></div><div>Lembaga keuangan yang tertarik untuk berpartisipasi dapat mengunjungi situs logosfi.com atau menghubungi hello@logosfi.com.</div><div><br></div><div>Tentang Logos</div><div>LogosFi, Inc. membangun infrastruktur bukti bersama bagi lembaga keuangan yang menggunakan aset yang ditokenisasi, stablecoin, dan uang digital. Infrastruktur ini memungkinkan bukti digunakan kembali sekaligus memastikan bukti tetap dapat ditelusuri ke sumber asalnya, serta mempertahankan kebijakan, pertimbangan, dan akuntabilitas setiap lembaga keuangan.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Wed, 21 Oct 2026 06:31:00 +0700</pubDate>
</item>
<item>
<title>STAR Systems Expands Product Lineup with Four OmniAir Certified Transponders</title>
<link>https://relleaseid.com/berita-bisnis/STAR-Systems-Expands-Product-Lineup-with-Four-OmniAir-Certified-Transponders</link>
<description><![CDATA[<img src=https://relleaseid.com/photo/berita/dir102026/9727_STAR-Systems-Expands-Product-Lineup-with-Four-OmniAir-Certified-Transponders.jpg border=0 hspace=5 align=left width=350 /><div><br></div><div>DALLAS, Oct. 19, 2026 (GLOBE NEWSWIRE) -- STAR Systems International, a global leader in tolling and vehicle identification technology, is proud to announce that four new innovative transponders have successfully achieved OmniAir Certification. </div><div><br></div><div>The newly certified products include the Xenius windshield sticker transponder, Terra license plate transponder, Genesis hardcase transponder, and Falcon dual-frequency transponder. With these additions to its OmniAir Certified portfolio, STAR Systems offers tolling agencies a broader range of high-performance, interoperable transponder solutions in a variety of form factors designed to meet diverse operational needs and vehicle requirements.</div><div><br></div><div>Four New OmniAir Certified Transponders from STAR Systems</div><div><br></div><div>Each newly certified transponder offers unique capabilities designed to address a variety of vehicle identification applications. The Xenius transponder provides a compact, high-performance windshield sticker solution for efficient vehicle identification, while the Terra transponder provides a versatile alternative in a license plate-mounted form factor. </div><div><br></div><div>The Genesis transponder features a durable hardcase design that gives motorists greater flexibility and control over occupancy declaration for express lanes. The Falcon transponder combines ultra-high frequency (UHF) RFID and Near Field Communication (NFC) technology in a single transponder, expanding opportunities for customer interaction and connected applications beyond traditional tolling.</div><div><br></div><div>"Congratulations to STAR Systems International on expanding its portfolio of OmniAir Certified transponders," said Jason Conley, Executive Director of OmniAir Consortium. "OmniAir Certification provides tolling agencies with confidence that products meet established industry standards for performance and interoperability. STAR Systems&#039; continued commitment to certification helps advance the adoption of reliable, standards-based electronic toll collection technologies." These four certifications further strengthen STAR Systems&#039; comprehensive transponder portfolio, offering tolling agencies greater flexibility in selecting solutions tailored to their operational requirements.</div><div><br></div><div>"Achieving OmniAir Certification for these four products reflects our continued investment in adopting next-generation chip technologies that bring new capabilities to our customers," said Robert Karr, CEO of STAR Systems. "It also supports our long-term product lifecycle management strategy, helping ensure a stable and reliable supply while continuing to deliver the interoperability and performance our customers expect."</div><div><br></div><div>For more information about STAR Systems&#039; OmniAir Certified transponders, readers, and antennas, please contact STAR Systems at salesinquiry@star-int.net.</div><div><br></div><div>About STAR Systems International&nbsp;</div><div>Founded in 2013, STAR Systems International is a world leader in Automatic Vehicle Identification Technologies. STAR Systems focuses on providing best-in-class transponders, onboard units, readers, roadside units and professional consulting services for Intelligent Transportation Initiatives, including Electronic Tolling (ETC), Urban Congestion, Road Use Charging, Electronic Vehicle Registration (EVR), Express/HOT Lanes, Fleet Management, Parking and Secure Access Control applications.</div><div><br></div><div>STAR Systems strives to ensure customer success by leveraging the Company&#039;s technical expertise and implementation experience. For more information, please visit www.star-int.net.</div><div><br></div><div>Copyright 2026 GlobeNewswire, Inc.</div>   ]]></description>
<pubDate>Tue, 20 Oct 2026 15:07:00 +0700</pubDate>
</item></channel></rss>